High-Yield Medical Revision Notes
High-Yield Medical Revision Notes
High-Yield
HOW TO USE THIS NOTE
CONGRATULATIONS
High-Yield Series
You now posses the book that will guide Medical PG Aspirants to score the
• High-Yield content best rank in PGMEE. With appropriate care, the binding should last the
specifically designed useful life of the book. Keep in mind that putting excessive flattening
for rapid revision
pressure on any binding will accelerate its failure. If you purchased a book
• Clinical based
that you believe is defective, please immediately return it to the place of
questions included
purchase.
• Clinical formulas
included FOR BETTER RESULTS
• Topics based on Use as revision book :
Previous Question Use this notes for revision as a supplement to your primary resource.
papers included These notes are specifically designed for active recall and visual memory
for reinforcing the revision strategy. Best results are gained on quick
recap a week before exam.
BOX ANNOTATION :
We have introduced concept of Box annotation
1. RED BOX : Includes the most repeated topic along with the next
potential MCQ that we believe will be tested in future exam
COLOR CODE:
The notes are specifically color coded as follows
1. BLACK : Definition
5. GREEN: Treatment
Cardiovascular Diseases
Heart failure
Abnormality of cardiac structure and/or function resulting in clinical symptoms
(e.g., dyspnea, fatigue) and signs (e.g., edema, rales), hospitalizations, poor
quality of life, and shortened survival.
Mechanisms of heart failure
Investigations
CXR may reveal cardiomegaly, pulmonary vascular redistribution, interstitial
edema, pleural effusions.
Prominence of
Reticular shadowing upper lobe Enlarged
of alveolar oedema blood vessels hilar vessels
Diuretics
Order of therapy
ACE inhibitor
Angiotensin receptor blockers (ARBs) if pt is intolerant of ACE inhibitor
Clinical formula
Reduced ventricular Left: Raised JVP, Chest X-ray, ACE inhibitor, ARBs
contractility, Pulmonary oedema, BNP elevated, Diuretics, Beta
Ventricular outflow Cardiomegaly, Serum urea, blockers,
obstruction, Pleural effusion, creatinine and Spironolactone
Heart Ventricular inflow electrolytes,
Pitting oedema Hydralazine plus an
failure obstruction, Right: Raised JVP, haemoglobin, oral nitrate, Digoxin,
Ventricular volume hepatomegaly, thyroid Transplant/
overload, Arrhythmia ascites, Pitting function, ECG , ventricular assist
Diastolic dysfunction oedema echo, Doppler device evaluation
Syncope
Transient, self-limited loss of consciousness due to acute global impairment of
cerebral blood flow.
• cardiac syncope due to mechanical cardiac dysfunction or arrhythmia
• neurocardiogenic syncope, in which an abnormal autonomic reflex
causes bradycardia and/or hypotension
• postural hypotension, in which physiological peripheral vasoconstriction
on standing is impaired, lead to hypotension.
Vasovagal syncope
Triggered by a reduction in venous return due to prolonged standing,
excessive heat or a large meal.
Mediated by the Bezold–Jarisch reflex
Head-up tilt-table testing is a provocation test used to establish the diagnosis,
A positive test is characterised by bradycardia (cardio-inhibitory response) and/or
hypotension (vasodepressor response) associated with typical symptoms.
13
l
Excessive peripheral venous pooling
Venous return
SYNCOpe
Treatment
Lifestyle modification
Salt supplementation and avoiding prolonged standing, dehydration or missing meals
Medical treatment
Fludrocortisone - causes sodium and water retention and expands plasma volume
Disopyramide - a vagolytic agent
Midodrine - a vasoconstrictor α-adrenoceptor agonist
Beta-blockers - inhibit the initial sympathetic activation
Clinical formula
Cardiac syncope:
Palpitations, chestpain, Blood sugar, Salt supplementation
breathlessness sodium and urea, and avoiding prolonged
Neurocardiogenic syncope: ecg, Echo standing, dehydration
Syncope Nausea, sweating, Holter monitoring, or missing meals,
lightheaded Carotid sinus Fludrocortisone
Postural hypotension, massage Disopyramide
Confusion, hyperexcitability, Tilt-table test Midodrine
olfactory hallucinations, aura CT head B blocker
Clinical Features
(1) new onset of severe angina,
(2) angina at rest or with minimal activity,
(3) recent increase in frequency and intensity of chronic angina.
Pathophysiology
Clinical
features
Risk
assessment
15
Pathogenesis
In unstable angina, myocardial ischaemia results from a primary decrease in
oxygen delivery rather than in increase in myocardial oxygen demand
Diagnostic criteria of unstable angina
• Angina on effort of recent onset (one month).
• Angina of effort with increasing frequency and duration and provoked by less
than usual stimuli (accelerated or crescendo angina).
• Prolonged (>20 min) anginal pain at rest
• Angina in early (<1 month) post-infarction period.
• New onset (de novo) severe angina,
• Recent destabilization of previously stable angina with crescendo angina
• Post MI angina
NSTEMI
Unstable angina
Ischemic discomfort with at least one of three features:
1. Occurs at rest , usually lasting
2. Severe and of new onset
3. Occurs with a crescendo pattern
NSTEMI is Unstable angina with evidence of myocardial necrosis in elevated cardiac
biomarkers.
Pathophysiology
1. Plaque rupture or erosion with a superimposed nonocclusive thrombus
2. Dynamic obstruction (coronary spasm as in Prinzmetal’s variant angina)
3. Progressive mechanical obstruction
4. UA secondary to increased myocardial oxygen demand or decreased supply
Clinical Features
Symptoms
● Pain: like that of angina but more severe and prolonged.
● Breathlessness.
● Vomiting:due to vagal stimulation, particularly in inferior MI.
● Syncope or sudden death due to arrhythmia.
● MI may occasionally be painless, especially in diabetic or elderly patients.
Signs
• Mild fever • Diffuse apical impulse
• Pallor, sweating • Soft first heart sound
• Tachycardia or bradycardia • Third heart sound
• Arrhythmias • Pericardial friction rub
• Narrow pulse pressure • Systolic murmur due to mitral regurgitation or
• Raised JVP uncommonly due to VSD
• Basal crepitations
18
Troponins
Specific markers for myocardial infarction
3 Types
1. Troponin C (calcium binding subunit)
2. Troponin I (actomyosin ATPase inhibitory subunit)
3. Troponin T (tropomyosin binding subunit).
not increased in muscle injury unlike CK
Normal values
cardiac troponin T: <0.1 ng/mL
cardiac troponin I: <0.03 ng/mL
19
Electrocardiogram
Laboratory Investigations
• Leucocytosis with a peak on 1st day.
• Raised ESR that may remain so for days.
• Elevated C-reactive protein.
• Chest radiography.
• Heart size is usually normal. Enlargement of cardiac shadow may indicate
previous myocardial damage or pericardial effusion.
• Evidence of pulmonary oedema.
• Radionuclide scanning shows the site of necrosis and the extent of impairment of
ventricular function.
• Echocardiography for regional wall motion abnormality and ejection fraction.
Brugada syndrome
V3) followed by inverted T waves, incomplete or complete right bundle branch block, and
susceptibility to ventricular tachyarrhythmia (particularly poly morphic ventricular
tachycardia) and sudden cardiac death.
• Genetically transmitted as an autosomal dominant syndrome with incomplete
penetrance.
• Syncope due to tachyarrhythmia usually occurs during sleep or at rest.
• Typically presents in third or fourth decade.
• Similar ECG patterns are seen in anterior wall infarction, arrhythmogenic right
ventricular dysplasia, acute pericarditis, Duchenne muscular dystrophy, hypercalcaemia
and hyperkalaemia.
• Treatment involves implantable cardioverter defibrillator (ICD) in patients who have
experienced at least one attack of cardiac arrest. Quinidine may be used if ICD
implantation is not feasible. It can also be used along with ICD to reduce number of
shocks delivered by ICD.
22
Clinical features
• Local – Precordial discomfort or anginal pain. Disagreeable fluttering over
precordium. Fullness in neck. Pounding of vessels in head, arms, abdomen and leg.
• Psychic and reflex nervous symptoms – Anxiety, coldness, sweating, and
dizziness. Abdominal distension, nausea and vomiting. Polyuria at end of attack.
• Cardiovascular – If heart diseased or paroxysm prolonged –
(a) Symptoms due to cerebral ischaemia – Syncope or AdamsStokes syndrome.
(b) Cardiac failure especially when there is underlying heart disease or in children
Electrocardiogram
• The P wave is usually buried in the QRS complex or occurs slightly before or after
the QRS complex.
• The QRS complexes occur at regular intervals (there is constant RR cycle length
• Significant ST segment depression during tachycardia
Treatment
Vagal manoeuvres like carotid sinus massage, Valsalva manoeuvre and gag reflex are
useful - delay conduction in AV node in a patient with circuit tachycardia.
If vagal manoeuvres are unsuccessful, drug therapy is warranted. They prolong the
AV refractory period.
Synchronised cardioversion is performed if patient is hemodynamically compromised.
Long-term control can be achieved by radiofrequency ablation of the re-entrant
pathway.
23
Clinical formula
digoxin toxicity
Action
• Increases myocardial contractility.
• Prolongs the refractory period of AV node, thereby slowing ventricular rate.
• Reflex vasodilatation from withdrawal of sympathetic constrictor activity in
patients with congestive heart failure.
Cardiac manifestations
Bradycardia
Multiple ventricular ectopics
Ventricular bigeminy
Paroxysmal atrial tachycardia with block
Ventricular tachycardia (VT)
Ventricular fibrillation
Conduction defects
Investigations
(a) ECG – Arrhythmias, changes of hyperkalaemia (in acute overdose):
ST-T wave changes; decreased QT interval.
(b) Serum K – Increased in acute overdose, decreased or normal in chronic overdose.
(c) Serum digoxin – High in acute overdose (>10 µg/litre if severe toxicity).
Management
• Stop digoxin, check urea, electrolytes and plasma digoxin concentration
• Correct hypokalaemia and dehydration
• Correct bradycardia using atropine or pacing
• Treat atrial tachycardia with J3-blockers
• Treat VT with lignocaine or amiodarone
• Antidigoxin antibodies rarely needed
25
Cause
A strip of accessory conducting tissue allows electricity to bypass the AV
node and spread from atria to ventricles without delay.
Clinical features
This tract can act as a re-entry pathway and the patient may develop supraventricular
tachycardia.
Complications
Ventricular tachycardia,
Supraventricular tachycardia,
Ventricular fibrillation (VF)
Atrial fibrillation,
Death.
Treatment
Narrow complex tachycardia is treated in the same way as PSVT.
For broad-complex tachycardia,
Isopyramide, quinidine, flecainide, propafenone and amiodarone - increase the
refractory period and reduce the conduction rate through the bypass tract.
Radiofrequency ablation of the bypass tract can be done.
In patients with WPW syndrome and atrial fibrillation, cardioversion is the
treatment of choice.
Digoxin and verapamil shorten the refractory period of the accessory pathway
and must be avoided.
26
related CLINICAL question
Q. A 34-year-old man comes to the casualty with palpitations for the past 4 hours. He
has no associated chest pain, shortness of breath, or dizziness. His medical history is
significant with 3 prior episodes of supraventricular tachycardia. The patient does not
use tobacco or illicit drugs and drinks alcohol only on social occasions. On examination,
his blood pressure is 120/80 mm Hg and pulse is irregularly irregular. ECG shows atrial
fibrillation with a rate of 160/min. What is the probable diagnosis?
Clinical formula
Accessory Isopyramide,
Supraventricular
conducting tissue Short PR and quinidine,
tachycardia, Atrial
allows electricity slurring of the flecainide,
fibrillation,
WPW to bypass the AV upstroke of propafenone and
syndrome Ventricular
node and spread the QRS amiodarone,
tachycardia,
from atria to complex Radiofrequency
Ventricular
ventricles without (delta wave). ablation,
fibrillation (VF)
delay. cardioversion
Atrioventricular block
Second-degree AV block
Some atrial impulses fail to conduct to the ventricles, resulting in dropped beats.
Mobitz type I block (‘Wenckebach’s phenomenon’):
There is progressive lengthening of the PR intervals, culminating in a dropped
beat. The cycle then repeats itself.
It is sometimes observed at rest or during sleep in athletic young adults with
high vagal tone.
Mobitz type II block:
The PR interval of conducted impulses remains constant but some P waves are
not conducted.
It is usually caused by disease of the His–Purkinje system and carries a risk of
asystole.
Second-degree atrioventricular block (Mobitz type II).
The PR interval of conducted beats is normal but some P waves are not conducted. The
constant PR interval distinguishes this from Wenckebach’s phenomenon.
Stokes–Adams attacks
Episodes of ventricular asystole may complicate complete heart block, Mobitz type
II second-degree AV block and sinoatrial disease, resulting in recurrent syncope
28
Clinical formula
Causes of Complete Regular and slow ECG: Constant P-P and IV atropine, IV
Heart Block pulse (30-40/ R-R intervals but with infusion of B-
Lenegre's disease minute) Varying complete AV adrenergic agonists
Lev's disease intensity of S1, dissociation, i.e. the with dopamine,
AV Myocardial ischaemia High volume atria and ventricles beat epinephrine or
block or infarction pulse, Stokes- independently and there transcutaneous
lntracardiac surgery Adams attacks, is no relation between pacing, immediate
Digitalis intoxication Irregular cannon the P waves and the insertion of
Infective endocarditis waves on JVP QRS complexes. pacemaker.
Note the wide QRS complexes with ‘M’-shaped Note the wide QRS complexes with the loss of the Q
configuration in leads V1 and V2 and a wide S wave or septal vector in lead I and ‘M’-shaped QRS
wave in lead I. complexes in V5 and V6.
aortic regurgitation
Due to disease of the aortic valve cusps or dilatation of the aortic root .
The LV dilates and hypertrophies to compensate for the regurgitation.
Stroke volume of the LV may eventually be doubled or trebled, and the
major arteries are then conspicuously pulsatile.
As the disease progresses, left ventricular diastolic pressure rises and
breathlessness develops.
Causes of aortic regurgitation
32
• Pulsus bisferiens Results from a low diastolic pressure from aortic run-off
and high systolic pressure from increased stroke volume
33
Investigations
• ECG – Left ventricular hypertrophy, with diastolic overload pattern in severe AR.
• Chest X-ray – Enlargement of the left ventricle, with ‘duckback’ shape of left border.
Ascending aorta shows uniform enlargement.
• Echocardiography – is vital for examining aortic valve, determining size of aortic root
and assessing LV func tion. Aetiology of AR can thus be established. Severity of
regurgitation can be established from Colour Doppler study
Cardiac catheterisation and aortography: in assessing the severity of regurgitation,
aortic dilatation and the presence of coexisting coronary artery disease.
• Blood tests – Treponemal serology and determination of inflammatory indices in
patients with aortic wall disease.
Treatment
Treatment of the underlying cause
Rheumatic fever prophylaxis
Medical treatment of cardiac failure with digoxin, diuretics, salt restriction and fluid
restriction
Afterload reduction therapy
• Isosorbide dinitrate 20-40 mg 6 hourly
• Hydralazine 50 mg 6 hourly
• Captopril 25-50 mg 8 hourly or enalapril 5-10 mg twice daily
35
Asymptomatic patients with normal left ventricular (LY) size and systolic
function do not require surgery but should be monitored carefully for
development of symptoms, LY dysfunction or progressive LY dilatation.
Surgical therapy is required in symptomatic patients or those with LY ejection
fraction <50% or end-systolic LV diameter >55 mm (even if asymptomatic). It
involves aortic valve replacement (open or TAYI).
Clinical formula
aortic dissection
• Aortic dissection is caused by a tear of the intima. The dissection usually
propagates distally, but may also propagate proximally. The dissection usually
results in aortic dilatation, resulting in dissecting aneurysm of aorta.
• Afflicts males more than females in their fifth and sixth decades.
Conditions associated
• Hypertension (in majority)
• Cystic medial degeneration
• Marfan’s syndrome
• Ehlers-Danlos syndrome
• Previous surgery: Coronary bypass, replacement of aortic valve
• Pregnancy (usually third trimester)
36
Stanford classification:
Top panels illustrate type A dissections that involve the ascending aorta
independent of site of tear and distal extension;
Type B dissections (bottom panels) involve transverse and/or descending
aorta without involvement of the ascending aorta.
DeBakey classification:
Type I dissection involves ascending to descending aorta (top left);
type II dissection is limited to ascending or transverse aorta, without
descending aorta (top center + top right);
type III dissection involves descending aorta only (bottom left).
37
Clinical features
Symptoms
Sudden onset of severe anterior or posterior chest pain, with “ripping” quality;
maximal pain may travel if dissection propagates.
Additional symptoms relate to obstruction of aortic branches (stroke, MI),
dyspnea (acute aortic regurgitation), or symptoms of low cardiac output due to
cardiac tamponade (dissection into pericardial sac).
Signs
Sinus tachycardia common; if cardiac tamponade develops, hypotension, pulsus
paradoxus, and pericardial rub appear.
Asymmetry of carotid or brachial pulses, aortic regurgitation, and neurologic
abnormalities associated with interruption of carotid artery flow are possible
findings.
Investigations
The CXR may show broadening of the upper mediastinum and distortion of the aortic
‘knuckle’.
Transthoracic echocardiography can only image the first 3–4 cm of the ascending
aorta but transoesophageal echocardiography, CT and MRI are all very useful.
Spiral CT scan is the modality of choice for diagnosis.
Treatment
Type A dissection is preferably treated by emergency surgical correction.
Type B dissection that is stable and uncomplicated is preferably treated by
medical measures
Medical therapy is aimed at reducing cardiac contractility and systemic arterial
pressure to 100-120 mrnHg systolic.
Clinical formula
CXR: broadening of the Medical therapy is
Chest pain, with “ripping” upper mediastinum and aimed at reducing
quality; dyspnea Sinus distortion of the aortic cardiac contractility
tachycardia hypotension, ‘knuckle’. and systemic arterial
aortic pulsus paradoxus, and > Transthoracic >
dissection pressure.
pericardial rub appear. echocardiography. Endoluminal repair
Asymmetry of carotid or Spiral CT scan is the with fenestration of the
brachial pulses, aortic modality of choice for intimal flap or insertion
regurgitation, diagnosis. of a stent-graft.
Management
Penicillin is given to eliminate any residual streptococcal infection.
Bed rest lessens joint pain and reduces cardiac workload.
Cardiac failure should be treated as necessary.
High-dose aspirin (60–100 mg/ kg up to 8 g per day) usually relieves the
symptoms of arthritis and a response within 24 hrs helps to confirm the diagnosis.
Prednisolone 1–2 mg/kg produces more rapid symptomatic relief and is indicated
for carditis or severe arthritis, until the ESR returns to normal.
Patients are susceptible to further attacks of rheumatic fever if subsequent
streptococcal infection occurs, and long-term prophylaxis with penicillin should be
given, usually until the age of 21.
Infective Endocarditis
• Infective endocarditis is due to microbial infection of the heart valve or the lining
of cardiac chamber (endothelium).
Acute bacterial endocarditis (ABE) is caused by virulent organisms and runs its
course over days to weeks.
Subacute bacterial endocarditis (SBE) is caused by organisms of low virulence
and runs its course over weeks or months.
Haemophilus,
Aggregatibacter (formerly Actinobacillus),
Cardiobacterium, HACEK group
Eikenella
Kingella
41
THE MODIFIED DUKE CRITERIA FOR THE CLINICAL DIAGNOSIS
OF INFECTIVE ENDOCARDITIS
Definite endocarditis:
Two major, or one major and three minor, or five minor
Possible endocarditis:
One major and one minor, or three minor
42
Osler’s nodes – Tender, peasized nodules on pads of fingers and toes. Often
pale in the centre. May occur in crops. Fade after few days usually without breaking
down or leaving any residue. Either due to minute emboli in superficial terminal
vessels or due to vasculitis.
Janeway lesions – Large nontender macules on palms and soles, it is vascular
phenomenon due to septic embolization.
Roth's spots-circular retinal haemorrhages with white central spots
43
Investigations
Diagnosis: based on the modified Duke criteria .
Blood culture: the crucial investigation because it may identify the infection and
guide antibiotic therapy;
Echo- cardiography: allows detection of vegetations and abscess formation, as well
as assessment of valve damage.
Transoesophageal echo > transthoracic echo particularly for patients with
prosthetic heart valves.
A normochromic, normocytic anaemia and elevated WCC, ESR and CRP: common.
CRP is superior to ESR for monitoring progress.
Microscopic haematuria: usually present.
ECG: may show the development of AV block
Management
Any source of infection (e.g. dental abscess) should be removed as soon as
possible.
Empirical antibiotic therapy is with flucloxacillin and gentamicin if the
presentation is acute, or with benzylpenicillin and gentamicin if it is subacute or
indolent.
Subsequent antibiotic treatment is guided by culture results and is usually
continued for at least 4 wks.
Indications for surgery (debridement of infected material, valve replacement)
include heart failure, abscess formation, failure of antibiotic therapy and large
vegetations on left-sided heart valves (high risk of systemic emboli).
Clinical formula
Mitral stenosis
Left atrial pressure Left atrial dilatation
Management
Medical management consists of diuretics for pulmonary congestion, with
anticoagulants and rate-limiting agents in the presence of AF.
For persistent symptoms or pulmonary hypertension, balloon valvuloplasty is the
treatment of choice, although valvotomy is an alternative.
Valve replacement is indicated for severe reflux or rigid, calcified valves.
Clinical formula
Rheumatic fever, Dyspnoea, ECG: bifid P Diuretics for
Congenital mitral Orthopnoea and waves pulmonary
stenosis Paroxysmal Nocturnal (P mitrale) congestion, with
Coxsackie B virus, Dyspnoea, Pulmonary CXR: anticoagulants and
MITRAL SLE
STENOSIS Oedema,Haemoptysis, enlarged left rate-limiting agents in
Atrial myxoma, bronchitis, Symptoms atrium and the presence of AF.
(MS) Gout of right ventricular features of hypertension, balloon
Infective failure like peripheral pulmonary valvuloplasty is the
endocarditis, oedema, right congestion. treatment of choice,
Rheumatoid hypochondriac pain. Doppler valvotomy
arthritis echo Valve replacement
46
Kerley’s A line
These are thin, non-branching
lines radiating from the hilum,
may be 2–6 cm in length, found in
the mid- and upper zones of the
lung fields.
These lines are due to the thick
interlobar septa, much thinner
than the adjacent blood vessels,
which do not reach the lung edge
Kerley’s B line
These are transverse lines at the lung
base, perpendicular to the pleura,
usually 1–2 cm in length, seen laterally
in the lower zone, reach up to the lung
edge (blood vessel do not reach the lung
edge).
Kerley’s B line is due to the thickening
of the interlobar septa caused by
oedema
Causes of Kerley’s line :-
• Pulmonary oedema (usually B type).
• Mitral valvular disease.
• Pneumoconiosis.
• Lymphangitis carcinomatosa.
• Sarcoidosis.
• Fibrosing alveolitis.
• Alveolar cell carcinoma.
• Lymphangiectasia.
• Idiopathic.
47
Respiratory Disease
Pulmonary Function Tests
Lung capacities
Inspiration capacity= TV + IRV
Functional residual capacity = ERV + RV
Vital capacity = TV+ IRV+ ERV
Total lung capacity = VC+ RV
48
Clinical formula
Investigations
Plain radiograph
- 12-24 hours :
Chest x-ray features usually develop 12-24 hours after initial lung insult as result
of proteinaceous interstitial edema
- <1 week
Within one week, alveolar pulmonary edema (hyaline membrane) occurs due to type
1 pneumocyte damage.
- In contrast to cardiogenic pulmonary edema, which clears in response to diuretic
therapy, ARDS persists for days to weeks.
- The initial radiographic findings of ARDS clear, the underlying lung appears to
have a reticular pattern secondary to type 2 pneumocyte proliferation and fibrosis
ABG analysis
• In the early stages, the only abnormality is mild hypoxaemia (low Pa02). As the
disease progresses, hypoxaemia worsens and hypercapnia appears.
• In the late stages, there occurs severe hypoxaemia (low Pa02) and severe
hypercapnia (high PaC02).
51
Management
Clinical formula
Tachypnoea, shortly followed by Chest X-ray :diffuse,
dyspnoea, cyanotic. Crepitations extensive bilateral Initiate volume/
acute are more prominent and heard interstitial and alveolar pressure limited
respiratory throughout both lung fields, infiltrates appear ventilation
distress especially over basal areas. ("fluffy" or "soft" Oxygenate
syndrome Tubular breath sounds may be shadowing). Minimise acidosis
heard, hypotension and Mild hypoxaemia (low Diuretics
worsening of blood gas Pa02), hypercapnia
abnormalities lead to death.
52
Bronchial Asthma
Investigations
1. Chest radiograph may be normal, or show signs of segmental or lobar collapse.
2. Full blood count – Eosinophilia.
3. Sputum – Eosinophils, Charcot-Leyden crystals and at times Curschmann’s spirals may
appear purulent (due to eosinophilic leucocytes) in absence of infection.
4. Skin tests – may confirm allergens suggested by history.
5. Lung function test – Spirometry shows reduction in FEV1, FEV1/FVC ratio and peak
expiratory flow (PEF). Reversibility, which is one of characteristic feature of asthma, is
shown by >12% or 200 ml increase in FEV1 15 minutes after inhaled short acting β2
agonist or 2–4 weeks trial of oral corticosteroids.
6. Provocation (challenge) tests – Exercise challenge tests useful in young adults and can
be used to confirm diagnosis of asthma, since fall in FEV1 or PEFR occurs after 5–7
minutes of vigorous exercise in most patients with asthma.
7. IgE and IgE specific test – Elevation of total serum IgE supports diagnosis of atopy, and
measurement of frac- tions of IgE specific to one allergen, radioallergosorb- ent test
(RAST) can be useful in some patients in whom a specific allergy is suspected.
54
Management
Clinical formula
Dry irritant cough may precede X-ray hyperinflated lungs
or accompany attacks of Direct challenge tests: 1. B-adrenoreceptor
wheezy breathlessness, Histamine or methacholine agonists.
Anxiety, cyanosis, perspiration provocation test 2. Methylxanthines.
Bronchial and cold extremities. ABG analysis: hypoxaemia 3. Corticosteroids.
Asthma In auscultation, Inspiration and hypocarbia 4. Chromones.
short and high pitched, Skin hypersensitivity tests: 5. Anticholinergics.
expiration prolonged, plenty of wheal and flare reaction 6. Leucotriene inhibitors.
wheeze. Crackles heard at the eosinophilia. 7. Miscellaneousagents.
bases towards the end of an • Elevated serum IgE levels.
attack.
LUNG ABSCESS
Lung abscess is defined as necrotic area of lung parenchyma containing purulent material.
Lung abscess can have two modes of presentations: acute (<l month of
symptoms) and chronic (>l month of symptoms).
Clinical features
• General examination reveals anaemia, fever, finger clubbing, halitosis and
oronasal sepsis.
• Respiratory system examination may be normal in the early stages. Later, frank
signs of consolidation like dullness on percussion, increased vocal fremitus and
vocal resonance, bronchial breathing, crepitations and pleural rub appear. Once the
abscess cavity opens into a bronchus, signs of cavitation like cavernous or
amphoric bronchial breathing and coarse post-tussive crepitations appear.
Investigations
• Anaemia, leucocytosis and raised ESR.
• Sputum studies should include Gram's stain, Ziehl-Neelsen staining for acid fast
bacilli, aerobic and anaerobic cultures and their sensitivity and cytological
examination for malignant cells.
• Chest radiograph often shows radiolucency in an opaque area of consolidation.
The wall or the border of the cavity completely surrounds the lucent area and an
air-fluid level may be seen.
• Bronchoscopy is indicated to exclude malignancy, obtain specimens for studies
and for removal of secretions.
• CT scan of thorax can detect lung abscess with certainty.
Clinical formula
Anaemia, fever, finger Anaemia, leucocytosis and Clindamycin or β-
clubbing, halitosis and raised ESR, Gram's stain, lactam/β-lactamase
oronasal sepsis, Ziehl-Neelsen staining for combination, In
LUNG dullness on percussion, acid fast bacilli, secondary lung
ABSCESS increased vocal fremitus often shows radiolucency in abscesses, antibiotic
and vocal resonance, an opaque area of coverage should be
bronchial breathing, consolidation, Bronchoscopy, directed at the identified
crepitations and pleural CT scan of thorax pathogen,
rub appear.
58
Bronchiectasis
Bronchiectasis is defined as an irreversible abnormal dilatation of the bronchial tree.
ETIOLOGY
Impaired host defenses
- Cystic fibrosis (CF) (MCC in children)
- Primary ciliary dyskinesia, Kartagener syndrome, Young syndrome
- Primary immunodeficiency disorder, common variable
- Immunodeficiency: hypogammaglobulinemia, chronic granulomatous disease
- HIV/AIDS
obstruction
- Severe obstructive lung disease: asthma or COPD
- Neoplasm,bronchial carcinoid, bronchogenic carcinoma -Inhaled foreign bodies
postinfective (most common known non-CF cause in adults)
- Bacterial pneumonia and bronchitis, S. aureus, H. influenzae, B. pertussis
- Mycobacterial infection, e.g. tuberculosis, Mycobacterium avium-intracellulare
complex
allergic and autoimmune
- Allergic bronchopulmonary aspergillosis (ABPA)
- Connective tissue disease, e.g. rheumatoid arthritis,Sjögren syndrome,
systemic lupus erythematosus (SLE)
Congenital
- Alpha-1-antitrypsin deficiency
Clinical features
- Recurrent chest infections
- Productive cough more than 8 weeks
Cough is chronic and worse in the mornings. It is brought about by postural changes.
- Production of copious amounts of sputum
Sputum is characteristically copious, purulent and foul-smelling due to anaerobic
infections. Sputum production varies with posture and is maximum in the first 2 hours
after waking up.
- Hemoptysis.
Haemoptysis is due to rupture of the thin-walled vessels on the walls of dilated bronchi.
It is often recurrent and may
vary from slight blood-streaked sputum to massive fatal bleeding.
59
Investigations
X-rays CT and HRCT :
- Tram-track opacities -> cylindrical - Demonstrate the airways
bronchiectasis, -Able to a greater or lesser degree to
- Air-fluid levels may be seen in cystic - distinguish some of the various
bronchiectasis. underlying causes.
- Increase in bronchovascular markings. -Signet ring appearance is seen in
bronchiectasis.
Chest radiograph (A) reveals ill-defined perihilar linear opacities and “tram-track” lesions in
bilateral lung fields. Computed tomography shows cylindrical bronchiectasis in right upper
and middle lobes with mucous plugging at places (B). Cystic bronchiectasis is present in left
upper lobe (C)
TREATMENT
• Acute exacerbations should be treated with a 7- to 10-day course of antibiotics
targeting the causative or presumptive pathogen; H. influenzae and P. aeruginosa
are isolated commonly.
• Hydration and mucolytic administration, aerosolization of bronchodilators and
hyperosmolar agents (e.g., hypertonic saline), and chest physiotherapy can be used
to enhance secretion clearance.
• For pts with ≥3 recurrences per year, suppressive antibiotic treatment to mini-
mize the microbial load and reduce the frequency of exacerbations has been
proposed.
• In select cases, surgery (including lung transplantation) should be considered.
60
Clinical formula
Pneumonia
Pneumonia is defined as inflammation with exudative solidification of the lung
parenchyma, generally acute.
Pathological Stages
• Stage of congestion-just congestion of the vessels without alveolar
exudation; fine crepitations may be heard
• Stage of red hepatisation-intra-alveolar exudation especially with
RBCs; tubular bronchial breathing heard
• Stage of grey hepatisation-the exudation is of mainly WBCs with
minimal RBCs; tubular bronchial breathing heard
• Stage of resolution-the exudate is absorbed or removed by macrophages
& proteolytic enzymes; coarse crepitations heard
61
Causes
CLINICAL FEATURES
Symptoms: Onset often sudden although sometimes it follows a minor respiratory
infection of a few days dura- tion.
1. General symptoms of infection – Malaise, fever, rigors, and night sweats,
vomiting; in the elderly confusion and disorientation.
2. Pulmonary symptoms – Dyspnoea, cough, and sputum which is often blood-
stained or rusty and difficult to expectorate.
3. Pleural symptoms – Pain aggravated by cough, deep breath or movement, usually
localised to site of inflam- mation.
62
Investigations
Treatment
63
Clinical formula
Investigation
RB-ILD DIP
Central bronchial wall Diffuse (or patchy ) B/L symmetric
thickening,peripheral bronchial wall ground glass opacities tend to be
thickening,centrilobular nodules and even more prominent.
ground glasss opacities.
Honey combing if present indicates
worse prognosis.
Treatment
Discontinue smoking
Immunosuppressive agents ( Prednisone )
Cytotoxic agents ( Azathioprine and Cyclophosphamide)
Bronchodilators can also be used
Clinical formula
RB-ILD Discontinue
Predominantly occurs in bronchial wall smoking
active and cases of thickening,centrilobular Immunosuppressiv
heavy smokers. nodules and ground glasss e agents
Interstitial Occurs b/w 40 - 50yrs of opacities, Honey combing
lung disease ( Prednisone )
age DIP Cytotoxic agents
Dysnea Diffuse (or patchy ) B/L ( Azathioprine and
Cough symmetric ground glass Cyclophosphamide
Wheezing opacities Bronchodilator
ASBESTOSIS
Asbestosis refers to development of diffuse interstitial fibrosis secondary to
asbestos fiber inhalation.
-Subpleural reticulations
- Subpleural plaques and
- Sub pleural calcifications
Chest radiograph
- irregular opacities with a fine reticular pattern
- evidence of asbestos exposure such as calcified or noncalcified pleural plaques
may be evident.
- Pleural effusions and pleural plaques are common manifestations
67
(A) HRCT features of early asbestosis include subpleural (B) In more advanced disease, a coarse reticular
lines (arrowheads) and fine reticulation (arrows). These pattern with honeycombing, often
subtle abnormalities persisted on prone sections. indistinguishable from usual interstitial pneumonia
on HRCT, is seen. Note the calcified pleural plaques
in both examples.
SILICOSIS
- Silicosis is a fibrotic pneumoconiosis caused by the inhalation of fine particles of
crystalline silicon dioxide (silica).
Characterised by pulmonary oedema, interstitial inflammation and accumulation
of proteinaceous fluid rich in surfac tant within the alveoli.
Multiple small nodules with ground glass densities
Thickened interlobular and intralobular septa with CRAZY PAVING pattern
polygonal shape
Caplan’s syndrome. (A) Coal worker with rheumatoid arthritis. Multiple rounded
opacities are present (some are calcified). (B) There is a left-sided cavitating
pulmonary nodule (arrows) on a background of pneumoconiosis.
Clinical formula
PLEURAL EFFUSION
Pleural effusions are abnormal accumulations of fluid within the pleural space.
Empyema
(Split pleura sign)
Clinical features
73
Emphysema
Component of COPD characterised by abnormal permanent enlargement of the
airspaces distal to the terminal bronchioles.
It is caused by a combination of mechanical obstruction in the small airways from
inflammation and later scarring, and loss of elastic recoil of the lungs which makes
these airways more likely to collapse during expiration.
• Four types
–Paraseptal
–Centrilobular (MC)
–Panacinar/panlobular
–Irregular/paracicatricial
Clinical formula
PNEUMOTHORAX
- Presence of air in the pleural space.
- When this collection of gas is constantly enlarging with resulting compression of
mediastinal structures, it can be life-threatening and is known as a TENSION
PNEUMOTHORAX
Plain radiograph
- Visible visceral pleural edge is seen as a very thin, sharp white line
- No lung markings are seen peripheral to this line
- Peripheral space is radiolucent compared to the adjacent lung
- Lung may completely collapse
- Mediastinum should not shift away from the pneumothorax unless a tension
pneumothorax is present.
- Subcutaneous emphysema and pneumomediastinum may also be present.
75
Pulmonary embolism
- Embolic occlusion of the pulmonary arterial system.
- MC result from thrombotic occlusion,
and therefore called as Pulmonary thromboembolism
PATIENTS history
- Recent immobilization
- Surgery
- Active malignancy
- Hormone usage
- Previous episode of Thromboembolism saddle embolism is seen.
Physical examination
- Clinical signs of DVT
- Asymmetric pitting edema of lower limbs
- Prominent superficial collateral vessels
- Tenderness to palpation along the deep venous system
- Tachycardia
- Dyspnea
- Pleuritic chest pain
- Hemoptysis
77
Radiological findings
- Normal in 30% of patients
- Westermark’s sign (area of focal peripheral oligemia)
- Knuckle sign/Palla’s sign : an enlarged right descending pulmonary artery
- Hampton’s hump : peripheral wedge shaped opacity with convexity toward hilum
- Melting sign : infarct showing rapid clearing contrary to pneumonic consolidation
(melts like snow)
- Fleischner’s sign : elevated hemidiaphragm
Initial Screening :- D-Dimers (High negative predictive value to exclude PTE)
Gold standard :- Pulmonary angiography/ arteriogram
(A) Chest radiograph of a patient presenting (B) CT pulmonary angiography shows thrombi
with sudden onset shortness of breath. The in right and left main pulmonary arteries.
right lower zone shows an ill-defined opacity in Infarction is seen in right lower lobe (arrow)
the periphery of lung (arrow);
Wells criteria
Risk stratification score and clinical decision rule to estimate the probability
for acute pulmonary embolism (PE)
- Clinical signs and symptoms of DVT = 3
- An alternative diagnosis is less likely than PE = 3
- Heart rate more than 100 = 1.5
- Immobilization for 3 or more consecutive days or surgery in the previous 4 weeks = 1.5
- Previous objectively diagnosed PE or DVT = 1.5
- Hemoptysis = 1
- Malignancy (on treatment, treatment in last 6 months or palliative) = 1
a)0-1: low risk b)2-6: moderate risk c)>6: high risk
78
Investigation and management
Clinical formula
Normal CXR Sufficient oxygen should be
Clinical signs of DVT, ECG: sinus tachycardia and given to all hypoxaemic patients
Asymmetric pitting edema anterior Twave inversion to restore SpO2 to > 90%.
of lower limbs, Prominent ABGs: Typically show a Subcutaneous low molecular
Pulmonary superficial collateral reduced PaO2 and a normal weight heparin (LMWH) should
embolism vessels, or low PaCO2, be administered for at least 5
Tachycardia, Dyspnea, Ddimer, Ventilation/perfusion days and anticoagulation
Pleuritic chest pain, scanning, CTPA: This is now continued using oral
Hemoptysis the firstline diagnostic test anticoagulants, usually warfarin.
Thrombolytic therapy,caval filters
79
Clinical Features
• Heartburn (pyrosis) is deeply placed burning pain behind the sternum radiating to the
throat. It occurs after meals, brought on by bending, lifting weight and straining.
Heartburn occurs on lying down in bed at night and is then relieved by sitting up.
• Regurgitation of gastric contents into the mouth (acid eructation) without associated
nausea or retching.
• Tracheal aspiration with coughing or laryngismus or aspiration pneumonia results from
regurgitated gastric contents in the mouth.
• Odynophagia-painful swallowing.
• Transient dysphagia to solids due to oesophageal spasm.
• Persistent dysphagia to solids due to strictures or development of oesophageal
carcinoma.
• Iron deficiency anaemia due to blood loss.
• Extraoesophageal symptoms include hoarseness, sore throat, sinusitis, otitis media,
chronic cough, laryngitis, non atopic asthma, recurrent aspiration and pulmonary
fibrosis.
80
Barrett’s oesophagus
Investigations
Endoscopy
• Oesophagitis can be visualised and confmned by biopsy.
• Strictures can be visualised.
• Barrett's mucosa can be confirmed by biopsy.
24-hr pH monitoring:
Intraluminal pH and symptoms are recorded during normal activities.
A pH of <4 for more than 6–7% of the study is diagnostic of reflux.
Barium swallow and meal can reveal a hiatus hernia.
Bernstein test is done in patients with high clinical suspicion but negative endoscopy.
Perfusion of acid into the lower oesophagus may reproduce the symptoms.
Treatment
Lifestyle advice should cover weight loss, avoidance of dietary triggers, elevation
of the bed head, avoidance of late meals and giving up smoking.
Antacids, alginates and H2receptor antagonists relieve symptoms without healing,
while PPIs also heal oesophagitis in the majority, and are the treatment of choice
for severe reflux disease.
Recurrence is common and some patients require lifelong treatment.
Longterm PPI treatment increases the risk of enteric infections and of H. pylori-
associated gastric mucosal atrophy.
Laparoscopic surgery is reserved for patients who fail to respond, are unwilling to
take longterm PPIs or have severe regurgitation.
81
Clinical formula
Dysphagia
82
Schatzki ring
- Also called Schatzki-Gary ring
- Is symptomatically narrow esophageal
B-ring occurring in the distal esophagus
- Associated with a hiatus hernia.
- Intermittent dysphagia, especially to
solid food. (MC)
- A history of food impaction is also
very common
Zenker’s diverticulum
- also known as a pharyngeal pouch,
- Posterior outpouching of the hypopharynx,
just proximal to the upper esophageal
sphincter through a weakness in the muscle
layer called the Killian dehiscence.
- A Zenker diverticulum is a pulsion-
pseudodiverticulum and results from
herniation of mucosa and submucosa
through the Killian triangle (or Killian
dehiscence),
- A focal weakness in the hypopharynx at the normal cleavage plane
between the fibers of the two parts of the inferior pharyngeal
constrictor muscle - the cricopharyngeus and thyropharyngeus.
Plummer-Vinson syndrome
(Patterson-Kelly syndrome)
A syndrome characterised by:
• Dysphagia to solids
• Iron deficiency
• Koilonychia
• Glossitis
• Dysphagia is due to a thin web in the postcricoid area.
The web is formed of degenerated epithelial cells.
• Usually seen in postmenopausal females.
• Increased risk for developing squamous cell carcinoma of upper gastrointestinal tract.
Investigations
• Haemoglobin and PCV low.
• Peripheral smear shows rnicrocytic hypochrornic anaemia.
• Serum iron is low and iron binding capacity is increased.
• Bone marrow iron stores are depleted.
• Barium swallow may show the web.
• Videofluoroscopy and endoscopy better than barium swallow.
Treatment
• Treatment of iron deficiency anaemia with iron may be effective in resolving dysphagia.
• Endoscopic dilatation.
• Follow-up endoscopy at periodic intervals to detect development of carcinoma.
Classification
It may be divided into three distinct types based on manometric patterns:
- Type I (classic) with minimal contractility in the esophageal body
- Type II with intermittent periods of pan-esophageal pressurisation
- Type III (spastic) with premature or spastic distal esophageal contractions
Clinical features
It usually develops slowly in middle age with intermittent dysphagia for solids,
which is eased by drinking, standing and moving around.
Heartburn is absent, but some patients experience severe chest pain due to
oesophageal spasm.
As dysphagia progresses, nocturnal pulmonary aspiration develops.
Achalasia predisposes to squamous carcinoma of the oesophagus.
Barium-filled oesophagus
showing distension above
(arrow head) the narrow
gastro-oesophageal junction
Note: The abrupt narrowing
Chest radiograph showing gross enlargement of the lower end of
of the oesophagus due to achalasia oesophagus (bird beak sign)
85
Investigations
Endoscopy is essential to rule out carcinoma.
Barium swallow shows tapered narrowing of the lower oesophagus and a dilated,
aperistaltic and foodfilled oesophageal body.
Manometry confirms the nonrelaxing lower oesophageal sphincter and poor
contractility of the oesophageal body.
CXR may show widening of the mediastinum and features of aspiration.
Treatment
Endoscopic dilatation: Dilatation of the oesophageal sphincter using a
fluoroscopically positioned balloon improves symptoms . Endoscopic injection of
botulinum toxin into the sphincter induces remission but relapse is common.
Surgical myotomy: Performed either laparoscopically or as an open operation
Clinical formula
Middle age with intermittent Endoscopy, Barium swallow:
dysphagia for solids, which is tapered narrowing of the lower Endoscopic
eased by drinking, standing oesophagus,Manometry : non‐ dilatation,
Achalasia and moving around. severe relaxing lower oesophageal Surgical
chest pain due to sphincter . CXR: widening of myotomy
oesophageal spasm,nocturnal the mediastinum
pulmonary aspiration
Peptic ulcer
Peptic ulcer refers to an ulcer in the lower oesophagus, stomach or duodenum,
in the jejunum after surgical anastomosis to stomach, and in the ileum adjacent
to a Meckel's diverticulum.
• Approximately 90% of peptic ulcers are caused by Helicobacter pylori infection
or nonsteroidal anti-inflammatory drug (NSAID) use.
● Recurrent episodes of epigastric pain in relation to meals.
● Occasionally, vomiting; persistent daily vomiting suggests gastric outlet obstruction.
86
Causes
Pathogenesis
Antral inflammation leads to reduced
somatostatin production and, because
somatostatin has a negative feedback
effect on gastrin production, this results in
hypergastrinemia Gastrin acts on parietal
cells, resulting in high stimulated acid
production, increased duodenal acid load
and the formation of protective gastric
metaplasia in the duodenum,
Helicobacter pylori cannot colonize the
normal duodenum, but can colonize
gastric metaplasia, causing inflammation
and ulceration
Complications
• Upper gastrointestinal bleed
• Perforation
• Gastric outlet obstruction (with fluid and electrolyte imbalance)
• Gastric malignancy
• Pancreatitis (due to posterior penetration of ulcer)
87
Factors Gastric ulcer Duodenal ulcer
• Age More than 40 years 20-50 years
• Sex Equal in both sexes More in males
• Course of the illness Less remittent More remittent
• Episodes of pain Relatively longer in duration Relatively shorter in duration
• Antacids Relief of pain not consistent Relief of pain prompt
• Food Provokes the pain Relieves the pain
• Heart burn Less common More common
• Night pains Less common More common
• Anorexia and nausea More common Less common
Investigations
• Double contrast barium meal may show the uker as a crater or as a deformed
duodenal cap.
• Endoscopy can visualise the ulcer. Typical location is duodenal bulb and lesser
curvature of stomach. A biopsy can be taken from a gastric ulcer to rule out
malignancy (10% of gastric ulcers are malignant) and H. pylori infection.
• Tests for H. pylori.
• Serum gastrin and gastric acid analysis in patients suspected to have Zollinger-
Ellison syndrome.
88
Tests for H. pylori
Treatment
Clinical formula
Epigastric pain, burning in Double contrast Firstline therapy is a PPI,
character, Hunger pain, Pain barium meal, clarithromycin, amoxicillin or
relief by food,excessive Endoscopy ,Tests for metronidazole, H. pylori
Peptic salivation, heart bums, loss of
ulcer H. pylori.Serum eradication therapy, Cigarette
appetite and vomiting,Anorexia, gastrin and gastric smoking, aspirin and NSAIDs
nausea, fullness, bloating and acid analysis should be avoided.
dyspepsia.
Zollinger-Ellison syndrome.
Clinical formula
Gastrin stimulates Peptic ulcers, Hypersecretion of acid Omeprazole
acid secretion oesophagitis, ulceration, under basal conditions, Octreotide
Zollinger- through gastrin Diarrhoea, Signs of Serum gastrin is grossly Surgical
Ellison receptors on parietal hyperparathyroidism or elevated , EUS and resection,
syndrome. cells by inducing hypophyseal or radiolabelled Chemotherapy
release of histamine pancreatic tumour , somatostatin receptor
from ECL cells. (MEN 1 syndrome) scintigraphy.
Whipple's disease
• It is a chronic multisystem disease associated with malabsorption.
• It is caused by gram-positive bacteria, Tropheryma whippelii.
Pathogenesis
There are characteristic PAS positive macrophages in the small intestine and
other involved organs (including joints, lungs, central nervous system, heart and
eyes). These macrophages cause lymphatic blockade in the lamina propria of small
intestine causing malabsorption.
Clinical Features
• Eight times more common in males than in females.
• Symptoms are diarrhoea, chronic, migratory, non-destructive polyarthritis, weight loss
and abdominal pain. Steatorrboea is uncommon.
• Other features include migratory arthralgias, fever, ophthalmologic features and
neurologic features (dementia, nystagmus, myoclonus and ophtbalmoplegia in late stages).
• Signs include generalised lymphadenopathy, arthropathy, skin pigmentation, abdominal
distension and tenderness.
• Cardiac involvement leads to mitral and aortic regurgitation.
91
Investigations
• Elevated erythrocyte sedimentation rate and C-reactive protein.
• Tests for malabsorption.
• Negative rheumatoid factor.
• Jejunal biopsy and biopsy of other involved tissues show plenty of PAS positive
macrophages that contain small bacilli.
• PCR tests for T. whipplii in saliva, stool or joint fluid.
Treatment
Trimethoprim-sulphamethoxazole (double strength tablet) should be given twice
a day for 1 year. Oral treatment should be preceded by a 2-week course of
parenteral therapy with ceftriaxone (2 g daily) or by meropenem.
Clinical formula
Diarrhoea, chronic, migratory, non- Elevated ESR and CRP.
destructive polyarthritis, weight loss , Tests for malabsorption. Trimethoprim-
fever, ophthalmologic features and Negative rheumatoid factor. sulphamethoxaz
Whipple's neurologic features,generalised Jejunal biopsy : PAS ole, ceftriaxone
disease lymphadenopathy, skin pigmentation, positive macrophages that or meropenem.
abdominal distension and tenderness, contain small bacilli.
mitral and aortic regurgitation. PCR tests for T. whipplii
pseudomembranous colitis
- Yellowish green exudates
- Tough pseudomembrane is seen
- Common cause of antibiotic-associated diarrhea, and increasingly
encountered in sick hospitalized patients.
Clinical Features
- Diarrhea
- Fever
- Raised white cell count
- Abdominal pain with distension
92
C. difficile produces two toxins (A and B) which have both cytotoxic and
enterotoxic effects on the bowel.
Clinical manifestation is thought to be predominantly due to toxin B.
Exudate composed of fibrin, white cells and cellular debris forms a
pseudomembrane on the mucosa of the colon, which is characteristic.
Investigations
Definitive diagnosis is made by isolating C. difficile toxin in the stool sample.
Treatment
• Withdraw the offending drug.
• Oral or intravenous rehydration.
• Oral metronidazole 500 mg thrice daily for 10-14 days in mild to moderate cases.
• Oral vancomycin 125-500 mg 6 hourly for 14 days in severe cases.
• Oral vancomycin plus intravenous metronidazole in refractory cases.
• Intravenous vancomycin not effective.
• Oral probiotic therapy (use of live nonpathogenic bacteria to restabilise the gut
flora and provide colonisation resis tance against C. difficile) often used in
resistant or relapsed cases. Probiotics use organisms resistant to gastric acid.
Lactobacillus acidophilus and Saccharomyces boulardii produce proteases that
digest C. difficile toxins. However, clinical benefits not shown; may rarely produce
septicaemia.
• Antimotility drugs (loperarnide or diphenoxylate) should not be given as they can
precipitate toxic megacolon.
• Colectomy in severely ill, refractory patients.
93
Clinical Features
Bloody diarrhea, mucus, fever, abdominal pain, tenesmus, weight loss;
spectrum of severity (majority of cases are mild, limited to rectosigmoid).
In severe cases, dehydration, anemia, hypokalemia, hypoalbuminemia.
Investigations
Sigmoidoscopy/colonoscopy: mucosal erythema, granularity, friability, exudate,
hemorrhage, ulcers, inflammatory polyps (pseudopolyps). Barium enema: loss of
haustrations, mucosal irregularity, ulcerations.
Crohn's disease
Crohn's disease is characterised by patchy and transmural inflammation, which
may affect any part of the gastrointestinal tract.
95
Investigations
Sigmoidoscopy/colonoscopy, barium enema, upper GI and small-bowel series:
nodularity, rigidity, ulcers that may be deep or longitudinal, cobblestoning, skip
areas, strictures, fistulas. CT may show thickened, matted bowel loops or an abscess.
Treatment
✗ ✗
Clinical formula
Ulcerative colitis: Crohn’s Ulcerative: Aminosalicylates (e.g.
Gradual onset Bloody disease:Abdominal mesalazine, sulfasalazine,
Sigmoidoscopy
pain, Diarrhoea, olsalazine)
Inflammatory diarrhoea ,proctitis with
rectal bleeding and Obstructive
/colonoscopy,
Crohn’s: Budesonide, thiopurine
Bowel barium enema
constipation.Urgency symptoms, Mass in (azathioprine or mercap topurine)
Diseases right iliac fossa,
and crampy abdominal or methotrexate
discomfort before Acute ileitis , Rectal Topical corticosteroids, IV fluids
defecation. bleeding, Proctitis and enteral nutritional support
97
chronic pancreatitis
Clinical Features
• Pain, acute or recurrent, continuous or intermittent.
May be referred to chest or back.
• Pain is often increased by alcohol or heavy meals.
• Features of local complications
(e.g. pseudocyst, obstruction of adjacent organs, or vascular thrombosis).
• Features of malabsorption-diarrhoea, steatorrhoea, weight Joss, features of
fat-soluble vitamin deficiency and vitamin B 12 deficiency (exocrine failure).
• Diabetes mellitus (endocrine failure).
• In late stages, mechanical obstruction of common bile duct can occur.
98
Investigations in chronic pancreatitis
Treatment
Alcohol avoidance- crucial in halting disease progression and reducing pain, but
advice is frequently ignored
NSAIDs are valuable but the severe, unremitting pain often leads to
opiate use with risk of addiction.
Abstinent patients with severe chronic pain resistant to conservative measures
may respond to surgical or endoscopic treat ment of strictures, calculi and
pseudocysts or coeliac plexus neuroly sis. Patients without such correctable
abnormalities require total pancreatectomy.
Fat restriction and oral pancreatic enzyme supplements: These measures
are used to treat steatorrhoea. A PPI is added to optimise duodenal pH for
pancreatic enzyme activity.
99
related CLINICAL question
Q. A 43-year-old man comes to the opd due to a 6-month history of intermittent
upper abdominal pain associated with nausea and weight loss . The patient describes
episodes of dull epigastric pain that are usually worse 15-30 minutes after meals and
last for a few hours. Pain is not relieved with antacids but improves when leaning
forward. He also has had occasional diarrhea.The patient consumes alcohol almost
daily. What is the probable diagnosis?
Clinical formula
Pain, acute or recurrent, USS, CT (may show Alcohol avoidance, NSAIDs,
continuous or atrophy, calcification surgical or endoscopic treat
chronic intermittent. or ductal dilatation), ment of strictures, Fat
pancreatitis increased by alcohol or AXR (may show restriction and oral
heavy meals,diarrhoea, calcification), MRCP, pancreatic enzyme
steatorrhoea, weight loss EUS supplements
Portal hypertension
Portal hypertension is defined as elevation of the hepatic venous pressure gradient to
>5 mmHg, which occurs as a consequence of cirrhosis.
It is caused by increased intrahepatic resistance to the passage of blood flow through
the liver due to cirrhosis together with increased splanchnic blood flow due to
vasodilatation within the splanchnic vascular bed.
Clinical features
Abdominal wall veins are often prominent and rarely, they may form a caput medusae
around the umbilicus.
Murmurs—A venous hum may be heard over the collaterals radiating occasionally to
the precordium or over liver (Cruveilhier-Baumgarten syndrome). A thrill may be
felt at the site of maximum intensity.
Spleen—Enlarges progressively, the edge is firm. Massive if presinusoidal portal
obstruction, cirrhosis with hypersplenism, rarely tropical splenomegaly.
Liver—High pressures are more often associated with a small, fibrotic liver. A soft
liver suggests extrahepatic portal venous obstruction, a firm liver cirrhosis.
Ascites—Portal hypertension raises capillary filtration pressure and increases
quantity of ascitic fluid.
101
Complications
Variceal bleeding: In cirrhotics risk of bleeding is related to:
Size of varices
Presence of red signs at endoscopy (red weal marks)
Degree of liver dysfunction
• Ascites
• Congestive gastropathy
• Hypersplenism
• Hepatic encephalopathy
• Kidney failure
Investigations
• Barium swallow usually shows varices as filling defects in the lower-third of
oesophagus ("bag of worms appearance").
• Upper gastrointestinal scopy.
• Most reliable method.
• Oesophageal varices are seen as blue rounded projections under submucosa.
• "Cherry red spots" indicate impending rupture.
Ultrasonography and Echo-Doppler ultrasonography should exclude an obvious
space-occupying lesion and establish patency of the portal and hepatic veins.
Portal venography demonstrates the site and often the cause of portal venous
obstruction and is performed prior to surgery. A typical ‘spider web’ appearance
on hepatic venography is diagnostic of Budd-Chiari syndrome.
Treatment
• Non-selective B-blockers (propranolol and nadolol) produce vasodilatation of both
splanchnic arterial bed and portal venous system along with reduced cardiac output.
• Nitrates (nitroglycerine and isosorbide dinitrate) reduce venous return and post-
sinusoidal resistance and are useful in combination with B-blockers in reducing risk of
variceal bleed.
• B-blockers with or without nitrates are used for primary prophylaxis of variceal bleed.
• Treatment of underlying disease.
102
Ascites
Accumulation of fluid within the peritoneal cavity,.
Most common cause - Portal hypertension related to cirrhosis.
Pathogenesis of ascites.
Clinical features
Increase in abdominal girth Development of peripheral edema
Shortness of breath Weakness
Malnourishment Muscle wasting
Excessive fatigue
puddle sign - Dullness over dependent abdomen with pt on hands and knees
Periumbilical nodule (Sister Mary Joseph’s nodule) or supraclavicular node
(Virchow’s node) suggests an abdominal malignancy
103
Investigation
Bulging flanks
Fluid wave
Presence of shifting dullness
USG or CT scan
Diagnostic paracentesis:- Determination of total protein and albumin content
Blood cells and differential count
Cultures
Algorithm for the diagnosis of ascites according to the serum-ascites albumin gradient (SAAG).
# High level of RBC signifies traumatic tap or hepaticellular C A or ruptured omental varix.
# Absolute level of PMNL is > 250/ul - ascitic fluid infection.
104
Treatment
Small amount of ascitic fluid can be managed by dietary restriction of sodium.
Advise to eat fresh and frozen foods. Avoid canned or processed foods.
Moderate amount of ascitic - Diuretic therapy is necessary
CIRRHOSIS
Cirrhosis is characterised by diffuse hepatic fibrosis and nodule formation,
Cirrhosis is the most common cause of portal hypertension and its complications.
Causes
• Alcohol • Biliary: primary or secondary biliary
• Chronic viral hepatitis (B or C) cirrhosis, cystic fibrosis
• Non-alcoholic fatty liver disease • Genetic: haemochromatosis, α1-
• Immune: primary sclerosing antitrypsin deficiency, Wilson’s disease
cholangitis, autoimmune liver disease • Chronic venous outflow obstruction
105
The Child-Pugh score is calculated
by adding the scores of the five
factors and can range from 5–15.
Child-Pugh class is either A (a score
of 5–6), B (7–9), or C (10 or above).
Decompensation indicates
cirrhosis with a Child-Pugh score of
7 or more (class B). This level has
been the accepted criterion for
listing for liver transplantation.
Clinical formula
Increase in abdominal Small amount of ascitic
girth, Shortness of breath, fluid can be managed by
Bulging flanks
Malnourishment dietary restriction of
Fluid wave
Ascites Excessive fatigue
Presence of shifting dullness sodium, Diuretic therapy
Development of peripheral with Spironolactone,
USG or CT scan
edema, Weakness, Furosemide , large
Diagnostic paracentesis
Muscle wasting volume paracentesis
106
Hematology
Iron deficiency anemia (peripheral blood). Megaloblastic bone marrow. The majority of cells are
Hypochromia, microcytosis, anisocytosis and target megaloblastic erythroblasts showing failure of nuclear
cells are shown development and abnormal nuclear morphology of
lymphocyte are visible and platelets are scattered
through the film
Anaemia
Clinical
manifestations of
Vit B 12 Deficiency
Clinical
Manifestations of
Aplastic anaemia
Clinical
Manifestations
of IDA
Clinical
manifestation
for
Hypoalbuminemia
109
White nails
Hyperpigmented
Knuckles
Hyper-pigmented knuckles in
megaloblastic anemia
Thalassemia
β- Thalassemia
-Anaemia
-Pale skin/ Jaundice
-Weakness
-Fatigue
-Protruding abdomen with
-Hepatosplenomegaly Thalassemic/Chipmunk facies Hair on end appearance
-Dark urine
-Abnormal facial bone and poor growth
-Poor appetite
-Delayed puberty (severe)
112
Investigations
Investigations done for Haemoglobin disorders:
i. Screening ☐ Haemoglobin electrophoresis
Ototoxicity •
GI symptoms - MC compared to others.
Retinal changes Kidney damage Most serious side effect :
•
truncal shortening
113
Hydroxyurea
•
DNA antimetabolite
•
Increases stress eryhtropoiesis which results in increased HbF production
•
Mean increase in hemoglobin of 1g ( range : 0.1 - 2.5g )
•
Initial starting dose for thalassemia intermedia is 10 mg/kg.
Hematopoeitic Stem cell Transplantation
Splenectomy
•
May be required in those who develop hypersplenism.
@
All patients should be fully immuniszed against encapsulated bacteria and on
long term penicillin prophylaxis.
Preventive Monitoring of
Thalassemia patients
•
Serial echocardiograms
•
Clinical formula
β- Thalassemia
α-Thalassemia -Anaemia Chelation therapy
-Anaemia -Pale skin/ Jaundice Haemoglobin Deferoxamine
-Pale skin -Weakness electrophoresis Deferasirox
-Weakness -Fatigue HPLC Deferiprone
Thalassemia -Fatigue -Protruding abdomen Globin Gene
-Hepatospleno -Hepatosplenomegaly Sequencing Hydroxyurea
megaly -Dark urine Hematopoeitic Stem
-Heart defects -Poor appetite cell Transplantation
-Delayed puberty Splenectomy
114
Kawasaki disease
Medium vessel vasculitis involving coronary artery
Most common vasculitis in childhood
CREAM criteria
Conjunctivitis
Rash (Polymorphic truncal rash)
Edema (of extremities in acute phase; skin peeling in subacute phase)
Adenopathy (cervical lymphadenopathy; single >1.5 cm)
Mucosal involvement (Strawberry tongue, erythematous lips)
RAYNAUD’S PHENOMENON
Vasoconstriction of peripheral blood vessels in response to cold or stress exposure
Cold exposure
Stress
Digital artery
contraction spasm
Occlusion of
arteries vasoconstriction - white
cyanosis - blue
Tissue ischemia rapid blood reflow- red
Diagnosis Treatment
Complete blood count Calcium channel blockers-
ESR Nifidipine
Antinuclear antibody Topical nitroglycerin
Rheumatoid factor
Transfusion reactions
Allergic
Due to transfer of lymphocytes from donor
TRALI
Transfusion associated lung injury
Usually occur due to plasma products
Neutrophil activation
Recruit IL-8
Damage endothelium of alveoli
Hyaline membranes
Acute lung injury
Clinical formula
Fever, chills, back pain, Get a coagulation Stop the transfusion
pruritus, burning screen including partial immediately
Acute
Haemolytic sensation and chest pain. thromboplastin time, If hypotension develops,
Transfusion In unconscious patient, platelet count, fibrinogen administer fluids and if
Reaction hypotension, shock, levels and fibrin- required, vasopressors.
haemoglobinuria, oliguria degradation products to Administer furosemide to
and excessive bleeding. exclude DIC. maintain urine output.
119
Anion gap
Measure of acid-base balance
AG = (Na+) - [ (CL-) + (HCO3-) ]
NA+
CL- HCO3- ANION GAP
1. Methanol 1. Ureteroenterostomy
2. Uraemia 2. Small bowel fistula
3. Diabetic ketoacidosis 3. Extra chloride
4. Phenformin, Paraldehyde 4. Diarrhoea
5. INH, Iron 5. Carbonic anhydride inhibitor
6. Lactic acid 6. Addison’s disease
7. Ethanol, Ethylene glycol 7. Renal tubular acidosis
8. Salicylates 8. Pancreatic fistula
MNEMONIC MNEMONIC
MUD PILES USED CARP
Seizure activity especially a tonic clonic seizure can significantly raise serum
lactic acid levels due to skeletal muscle hypoxia and impaired hepatic lactic
acid uptake and cause High anion gap metabolic acidosis (HAGMA)
120
DAVENPORT DIAGRAM
Clinical formula
Step 1. Check the pH Step 3. Choose Step 5. If metabolic
pH< 7.36, acidosis appropriate compensation acidosis present,
pH> 7.44, alkalosis for acid-base disorder calculate the anion gap
ACID-BASE
DISORDERS Step 2. Is primary process Step 4. Determine if Step 6. If high anion
metabolic or respiratory? For degree of compensation gap acidosis, calculate
this, check pC02 and HC03 is appropriate or not delta-delta gap
Kidney
Ig A Nephropathy
Minimal change Most common cause in world
disease
(Child) Post streptococcal
glomerulonephritis
Most common cause in india
Focal segmented
glomerular sclerosis
(Adults) Rapidly progressive
glomerulonephritis
End stage- Aggressive
Membraneous
Nephropathy
(Elderly)
acute glomerulonephritis
Post-Streptococcal Glomerulonephritis
One of the common causes of acute nephritic syndrome is acute post-
streptococcal glomerulonephritis (PSGN)
• Onset is often abrupt with puffiness of face, oliguria, smoky urine or reddish
urine, hypertension and oedema.
• The oedema of acute glomerulonephritis tends to appear initially in areas of low
tissue pressure (periorbital areas), but subsequently progresses to involve
dependent portions of the body, and may lead to ascites and/or pleural effusion.
Investigations
• Urine microscopy Red cells (particularly dysmorphic-i.e. distorted
and fragmented red cells), red cell casts
• Cultures Throat swab and swab from inflamed skin may
grow group A 13-haemolytic streptococci
• Antistreptolysin-0 (ASO) titre Elevated
• C3 level (complement) May be reduced
• Urinary protein Increased
• Urea and creatinine May be elevated
• Renal biopsy Features of glomerulonephritis
Treatment
• Treatment of acute PSGN is supportive.
• The measures include rest, salt restriction, diuretics and antihypertensives.
• Antibiotics are given for presumed throat infection as this may result in milder
form of nephritis. Further, treatment of a carrier state may prevent spread to
other household members.
• Dialysis is required in severe oliguria, fluid overload and hyperkalaemia.
• Steroids and cytotoxic drugs are of no value.
• Complications include pulmonary oedema, hypertensive encephalopathy and
renal failure.
124
IgA nephropathy
- Also known as IgA nephritis or Berger disease
- Most common glomerulonephritis worldwide and is a leading cause of chronic kidney
disease and renal failure.
Clinical features
• Characterised by predominant lgA deposition in the glomerular mesangium.
• Presents with painless haematuria, generally within 1-2 days of upper
respiratory infection.
• More common in children and young adults with peak incidence between 15
and 30 years.
Henoch-Schonlein purpura is a systemic disease which may have mesangial lgA
deposition. It is more common during childhood as compared to IgA nephropathy
A characteristic petechial rash (cutaneous vasculitis, typically affecting buttocks
and lower legs) and abdominal pain (GI vasculitis) usually dominate the clinical
picture, with mild glomerulonephritis indicated by haematuria.
May be detected on routine urine examination (microscopic haematuria).
Renal biopsy shows mesangial IgA deposition and appearances indistinguishable
from acute IgA nephropathy.
Management of IgA nephropathy is largely directed towards control of BP and
proteinuria reduction in an attempt to prevent or retard progressive renal disease.
Goodpasture syndrome
- Referred as anti glomerular basement membrane (anti-GBM) antibody disease
- Autoimmune disease characterized by damage to the alveolar and renal
glomerular basement membranes by an antibody.
Goodpasture syndrome is defined by:
- Pulmonary hemorrhage
- Glomerulonephritis
- Circulating anti glomerular
basement membrane antibodies.
Immunofluorescence
- Smooth
- Diffuse linear pattern
126
Investigations
• Leucocytosis and anaemia.
• Blood urea and serum creatinine levels usually elevated.
• Urinalysis shows modest proteinuria (1-4 g/day), microscopic haematuria, and RBC
and WBC casts.
• Complement levels (C3 and C4) may be decreased in patients with immune-complex
mediated RPGN.
• Circulating anti-GBM antibodies in Goodpasture syndrome.
• ANCA in patients with pauci-immune RPGN.
• Serum cryoglobulin levels may be elevated in cryoglobulinaemias.
• Abdominal ultrasound shows normal-sized kidneys.
• Chest X-ray in patients with Goodpasture syndrome and vasculitides may show
diffuse opacities if pulmonary haemorrhage occur.
• Kidney biopsy.
Treatment
• Control of infection
• Control of volume status (dialysis if required).
Immunosuppressive therapy (e.g. glucocorticoids, cyclophosphamide, azathioprine,
mycophenolate), plasma exchange (in patients presenting with life-threatening
pulmonary haemorrhage). Treatment of choice in anti-GBM antibody disease is
plasmapheresis combined with prednisolone and cyclophospharnide.
Infliximab and rituximab.
Clinical formula
nephrotic syndrome
The nephrotic syndrome is characterised by the following abnormalities
Proteinuria (>3.5 g in 24 hours)
Generalised oedema
Hypoalbuminaemia
Hyperlipidaemia
Causes
Treatment
• Measures to reduce proteinuria
• Measures to control complications of nephrotic syndrome
• Treatment of underlying cause
Clinical formula
24-hour urinary protein • Measures to reduce
Proteinuria (>3.5 g in estimation, and estimation of proteinuria- ACE
24 hours) serum albumin and serum inhibitors,NSAIDs
nephrotic • Measures to control
syndrome Generalised oedema cholesterol concentrations.
Hypoalbuminaemia Red cells and red cell casts complications of nephrotic
Hyperlipidaemia may be present in the urine. syndrome- salt restriction, rest
and judicious use of diuretics
Investigations
131
Treatment
• Therapy for ARF is directed at correcting fluid and electrolyte abnormalities, treating
the underlying cause and prevent ing complications including nutritional deficiencies.
• Emergency treatment should be started for hyperkalaemia (K+ >6 mmol/L) to prevent
life-threatening complications.
• Acidosis should be treated with intravenous or oral bicarbonate if serum bicarbonate
level is <15 mEq/L.
• Drugs such as loop diuretics, mannitol and dopamine have been used to increase urine
output and reduce the duration of renal failure but they have been shown to be of no value.
• Dietary proteins should be restricted
• If conservative measures fail, haemodialysis may be required.
Staging of CKD
133
Hyperkalemia in CKD
Hyperkalemia is is the most critical manifestation of Chronic kidney disease.
It may lead to Diastolic arrest.
K+ > 5.0 mEq/L
Acute reduction is required at levels >7.0 mEq/L
ECG - Tall peaked T waves
TREATMENT
i. IV Calcium - most rapid and effective way to antagonize myocardial toxic effect
ii. IV insulin
iii. B2 Adrenergic agonist
iv. Haemodialysis if hyperkalemia is persistent or severe
Urine Crystals
Clinical features
- Some renal stones : Asymptomatic
- Most will result in pain.
- Small stones that arise in the kidney are more likely to pass into the
ureter where they may result in renal colic.
-Hematuria may also be present.
Plain radiograph
1)Calcium-containing stones are radiopaque:
- Calcium oxalate +/- calcium phosphate
- Struvite (triple phosphate) - usually opaque but variable
- Pure calcium phosphate
2)Lucent stones include:
- Uric acid
- Cystine
- Medication (indinavir) stones
lupus nephritis
135
Nocturnal Enuresis
Refers to the occurrence of involuntary voiding at night after 5yrs of age.
Nocturnal enuresis
Primary Secondary
75-90% 10-25%
Urinary control never achieved Child was dry for few months
and then enuresis developed
Causes
i. Delayed maturation of cortical mechanism that allow voluntary control of
micturition reflex.
ii. Defective sleep arousal
iii. Sleep disorders
iv. Constipation
Treatment
Best approach is to reassure the child and parents that the condition is self limited and
avoid punitive measures that can affect child’s psychological development adversely
Fluid intake should be restricted after 6-7pm
Parents should be certain that child voids at bedtime
Conditioning therapy : involves use of loud auditory or vibratory alarm attached to
moisture sensor in undergarment.
Pharmacological therapy : 2nd line - Desmopressin acetate (Synthetic analogue of ADH )
Clinical formula
i. Delayed maturation of cortical Reassure the child and
mechanism that allow voluntary parents
Involuntary voiding Fluid intake should be
Nocturnal at night after 5yrs control of micturition reflex.
ii. Defective sleep arousal restricted after 6-7pm
Enuresis of age. Conditioning therapy ,
iii. Sleep disorders
iv. Constipation Pharmacological therapy : 2nd
line - Desmopressin acetate
136
Endocrinology including DM
anterior pituitary hormone deficiency
Hypopituitarism means the combined deficiency of any of the anterior pituitary hormones.
Causes
Sheehan's syndrome
• Results from infarction of pituitary gland during post-partum period.
• Post-partum pituitary infarction occurs because the enlarged pituitary gland of
pregnancy is more vulnerable to ischaemia of post-partum haemorrhage and systemic
hypotension.
• Failure to lactate is the earliest symptom.
• Another typical symptom is failure to regain menstruation after delivery and breast
involution.
• Other symptoms of hypopituitarism appear over months or years, though some
patients present acutely.
• Uncommonly, it can present acutely with circulatory collapse, severe hyponatraemia,
diabetes insipidus, hypoglycae mia, congestive cardiac failure, psychosis, finally leading to
coma and death.
• MRI may show hypertrophic pituitary in early stages, but later, atrophic pituitary and
empty sella develop. It also excludes a pituitary mass.
• Treatment is substitution of deficient hormones.
137
Investigation of pituitary and hypothalamic disease
Treatment
Cortisol replacement: Hydrocortisone is used
Thyroid hormone replacement: Levothyroxine 50–150 µg once daily should be given.
Sex hormone replacement: for gonadotrophin deficiency in women < 50 and in men.
Growth hormone (GH) replacement
Clinical formula
Failure to lactate , failure Short ACTH stimulation test; Hydrocortisone
to regain menstruation insulin tolerance test, serum Levothyroxine
after delivery , circulatory testosterone, LH, FSH;serum T4; Sex hormone
Sheehan's TSH , blood glucose, potassium
syndrome collapse, severe replacement
hyponatraemia, diabetes and calcium measurements; Growth hormone (GH)
insipidus, hypoglycaemia water deprivation test or 5% replacement
saline infusion test
138
acromegaly
• GH hypersecretion occurring in adult life after epiphyseal closure results in
acromegaly (excess before epiphysis closure results in gigantism).
• Pituitary tumour (somatotroph pituitary adenoma) is the most common cause.
• Rare causes include excessive GH secretion from pancreatic islet cell tumour, or
excessive secretion of GR-releasing hormone from hypothalamic lesions, bronchial
carcinoid and small cell lung carcinoma.
Clinical features
• Soft tissue changes Thickening of skin, increased skin tags, acanthosis nigricans,
increased sweat and sebum resulting in moist and oily skin,
enlargement of lips, nose and tongue, increased heel pad
thickness, visceral enlargement-e.g. thyroid, heart and liver,
carpal tunnel syndrome, myopathy, sleep apnoea, Raynaud's
phenomenon
• Bone changes Large spade-like hands, large feet, prognathism, prominent
supraorbital ridges, large frontal sinuses, wide-spacing of the
teeth, arthropathy, kyphosis, osteoporosis
• Metabolic effects Glucose intolerance or clinical diabetes mellitus
Treatment
The primary treatment modality for acromegaly is transsphenoidal surgery
• Bromocriptine or cabergoline (dopamine receptor agonists) in mildly elevated IGF-1.
• Octreotide or lanreotide (somatostatin analogues)- act on pituitary somatostatin
receptors to produce inhibition of GH and IGF-1.
• Pegvisomant, a GH receptor antagonist, blocks peripheral IGF-1 action
Clinical formula
Large spade-like hands, • Investigations of pituitary
large feet, prognathism, • Bromocriptine or
tumour
prominent supraorbital cabergoline
• Elevated IGF-I levels.
acromegaly ridges, large frontal sinuses, • Octreotide or
• GH levels are measured
wide-spacing of the teeth, lanreotide
during an oral glucose
arthropathy, kyphosis, • Pegvisomant,
tolerance test (OGTT).
osteoporosis
diabetes insipidus
Diabetes insipidus (DI) can be divided into following types:
• Deficient production of ADH.
Primary deficiency (neurogenic, pituitary, hypothalamic, cranial or central DI)
occurs due to agenesis or destruc tion of neurohypophysis.
Secondary deficiency occurs due to inhibition of ADH secretion (primary
polydipsia).
Deficient action of ADH (nephrogenic DI).
140
Causes of diabetes insipidus
Clinical Features
• Polyuria, excessive thirst and polydipsia (with predilection for cold drinks)
are the cardinal manifestations of DI.
• Daily urine output >50 mL/kg/day and may reach as high as 10-15 L.
• In traumatic DI triphasic response may be seen: initial polyuria, prolonged
antidiuresis and final polyuria.
Diagnosis
• The urine is clear and of low specific gravity. The osmolality is low.
• Serum sodium is borderline high indicating water loss.
• Water deprivation test
• MRI of pituitary and hypothalamus.
Treatment
• Desmopressin 10-20 µg intranasally once or twice a day.
• Chlorpropamide enhances the renal responsiveness to vasopressin.
• Carbamazepine is an alternate drug with similar action.
• Thiazide diuretics (e.g. bendrofluazide) are the only effective drugs for nephrogenic DI.
Clinical formula
• The urine is clear and of
Polyuria, low specific gravity. • Desmopressin
excessive • Serum sodium is • Chlorpropamide
diabetes borderline high. • Carbamazepine
insipidus thirst and
polydipsia • Water deprivation test • Thiazide diuretics (e.g.
• MRI of pituitary and bendrofluazide)
hypothalamus.
adrenocortical insufficiency
Addison's disease
Clinical features of Addison's disease result from glucocorticoid deficiency,
mineralocorticoid deficiency, androgen deficiency and ACTH excess.
Manifestations include fatigue, weakness, anorexia, nausea and vomiting, weight loss,
abdominal pain, cutaneous and mucosal pigmentation, salt craving, hypo- tension
(especially orthostatic), and, occasionally, hypoglycemia.
Routine laboratory parameters may be normal, but typically serum Na is reduced and
serum K increased.
Extracellular fluid depletion accentuates hypotension.
In secondary adrenal insufficiency, pigmentation is diminished and serum potassium is
not elevated.
Serum Na tends to be low because of hemodilution stemming from excess vasopressin
secreted in the setting of cortisol deficiency.
142
Investigations
• Elevated blood urea, hyponatraemia and hyperkalaemia.
• Low blood sugar levels.
• Mild anaemia, mild eosinophilia.
• Plasma cortisol measured between 8 and 9 am <3 mg/dL suggests adrenal insufficiency
• ACTH stimulation test
• Plasma ACTH levels are elevated (> 100 pg/dL) in primary adrenal insufficiency.
• PRA is high and plasma aldosterone levels are low or normal.
• Adrenal and other organ-specific antibodies (e.g. adrenal cortex antibodies, 21-
hydroxylase antibodies) may be detected in the serum in autoimmune adrenalitis.
Management
• Patients with Addison's disease require lifelong glucocorticoid and
mineralocorticoid replacement therapy.
• Cortisone is given at a dose of 20 mg on getting up in the morning and 10 mg in
the evening at 6 pm. Alternatively,Prednisolone is given in a dose of 5 mg in the
morning and 2.5 mg in the evening.
• Fludrocortisone (mineralocorticoid) 0.05-0.1 mg daily in patients with primary
adrenal insufficiency.
• During periods of stress and infections the patient should be told to take
additional doses of prednisolone.
Clinical formula
Fatigue, weakness, anorexia, Elevated blood urea,
nausea and vomiting, weight hyponatraemia and
loss, abdominal pain, Glucocorticoid and
Addison's hyperkalaemia, Low blood
mineralocorticoid
disease cutaneous and mucosal sugar levels, Mild anaemia,
pigmentation, salt craving, replacement therapy.
mild eosinophilia, Plasma
hypotension (especially cortisol, ACTH stimulation.
orthostatic), hypoglycemia.
143
Cushing’s syndrome
Cushing’s syndrome refers to the clinical manifestations induced by, chronic
exposure to excess corticosteroid.
Cushing disease is corticosteroid excess due to pituitary dependent bilateral
adrenal hyperplasia.
Causes
Clinical features
144
Management of the patient with suspected Cushing’s syndrome. ACTH, adrenocorticotropic hormone;
CRH, corticotropin-releasing hormone; DEX, dexamethasone.
146
RELATED CLINICAL QUESTION
Q. A 34-year-old woman comes to the opd due to a 6-month history of easy bruising with
minimal or no trauma. She also has had difficulty climbing stairs due to muscle weakness and
frequent nocturnal muscle cramps and weight gain. Her lmp was 3 months ago. Examination
shows facial plethora with dark terminal hair on her upper lip and chin. There is inflammatory
acne on her face and back, extensive tinea versicolor on the trunk, and scattered bruises over
the extremities. What is the probable diagnosis?
Clinical formula
Most patients are
Weight gain, Hirsutism, 24hr urinary cortisol and serum treated surgically, and
Oligomenorrhoea, Central cortisol that fails to suppress corticosteroid
Cushing’s obesity ("lemon on match- either with a 1mg overnight biosynthesis can be
syndrome stick") dexamethasone suppression test inhibited by metyrapone
Buffalo hump, Moon face, or with the 48hr lowdose or ketoconazole pending
Purplish striae dexamethasone suppression test operation.
Hypothyroidism
Clinical condition resulting from reduced production of thyroid hormone.
Myxoedema indicates severe hypothyroidism in which there is accumulation of
hydrophilic mucopolysac charides in the ground substance of the dermis and other
tissues, leading to thickening of the facial features and doughy induration of the skin.
CAUSES OF HYPOTHYROIDISM
147
Clinical features
Evaluation of hypothyroidism.
TPOAb+, thyroid
peroxidase antibodies
present; TPOAb–,
thyroid peroxidase
antibodies not present;
TSH, thyroid-
stimulating hormone.
Management
• Hypothyroidism is treated with T4• It is usually given at a dose of 50 µg/day for 3
weeks, followed by 100 µg/day for 3 weeks, followed by a maintenance dose of 150 µg/
day. The correct dose of T4 is that which restores serum TSH to below 3 mU/L. It
should be given on empty stomach in the morning.
• In elderly patients and those with ischaernic heart disease T4 is started at a lower
dose of 25 µg/day.
148
RELATED CLINICAL QUESTION
Q. A 39-year-old woman with abnormal uterine bleeding. The patient underwent menarche
at age 15 and had irregular menses that normalized with oral contraceptives. She also has
had difficulty concentrating at work due to increasing irritability and depressed mood. She
has no headaches or hot flushes. Vital signs are normal. BMI is 26 kg/m2. Skin is cool and
dry. Pregnancy test is negative. This patient's laboratory results would most likely reveal
which of the following?
Clinical formula
Tiredness, SerumT4 levels are low
andTSH levels are high, T4 at a dose of 50 μg/
somnolence, cold
Serum sodium levels may day for 3 weeks,
Hypothyroi intolerance,
be low.ECG: sinus followed by 100 μg/day
dism hoarseness of
bradycardia, low voltage for 3 weeks, followed by
voice, low-pitched
QRS complexes and ST-T a maintenance dose of
voice, slurred
wave abnormalities. 150 μg/day.
speech, weight gain
THYROTOXICOSIS
The term thyrotoxicosis refers to the clinical syndrome of hypermetabolism and
hypersensitivity which result from excessive amount of thyroid hormones
Causes
149
Evaluation of thyrotoxicosis
Evaluation of
thyrotoxicosis. aDiffuse
goiter, positive TPO
antibodies,
ophthalmopathy,
dermopathy; bcan be
confirmed by
radionuclide scan.
TSH, thyroid-
stimulating hormone.
Clinical features
Thyroid Diffuse or nodular enlargement
Gastrointestinal Weight loss, increased appetite, vomiting, increased stool
frequency, diarrhoea, steatorrhoea
Cardiorespiratory Exertional dyspnoea, exacerbation of asthma, palpitations,
angina, sinus tachycar dia, atrial fibrillation, wide pulse pressure,
cardiac failure, cardiomyopathy
Neuromuscular Nervousness, irritability, emotional ability, psychosis, fine
tremors, hyper-reflexia, ill-sustained clonus, muscle weakness,
proximal myopathy, bulbar myopathy
Dermatological Increased sweating, pruritus, palmar erythema, spider
naevi, onycholysis, alope cia, pigmentation
150
Graves' disease
Graves' disease is distinguished from other forms of hyperthyroidism by the
presence of diffuse thyroid enlargement with or without bruit, ophthalmopathy and
pretibial myxoedema.
Autoimmune disorder in which thyroid stimulating immunoglobulin (TSI) binds to
and stimulates thyroid stimulating hormone (TSH) receptor
on thyroid cell membrane resulting in excessive synthesis and secretion of thyroid
hormone.
- Excessive sweating, - Insomnia
- Fatigue - Tremors
- Palpations - Irritability
Thyrotoxic crisis
Thyrotoxic crisis, or thyroid storm, is rare, presents as a life-threatening exacer-
bation of hyperthyroidism, and can be accompanied by fever, delirium, seizures,
arrhythmias, coma, vomiting, diarrhea, and jaundice.
RELATED CLINICAL QUESTION
Q. A 58-year-old woman comes to the opd due to recent-onset tremor, palpitations,
weight loss, and fatigue.The patient's mother had hypothyroidism and osteoporosis.
On examination, there is diffuse, nontender enlargement of the thyroid gland.
Ocular examination shows bilateral proptosis, lid lag, and periorbital puffiness. The
patient has diplopia and ocular discomfort on extremes of lateral gaze. Laboratory
tests show a suppressed TSH and elevated thyroid hormone levels. What is the
probable diagnosis?
Clinical formula
- Excessive sweating, TSH , elevated levels ofbT3 and 1. Antithyroid drugs with
- Fatigue normal levels ofT4, AbsentTSH initial supplementation of
Graves' - Palpations response following a B-blocker.
disease - Insomnia intravenousTRH, Elevated 2. Surgicaltreatment.
- Tremors levels of antibodies toTPO, 3. Radioactive iodine.
- Irritability Measurement ofTRAb
151
Diabetes mellitus
Diabetes mellitus is a clinical syndrome characterised by hyperglycaemia due to
absolute or relative deficiency of insulin.
Type 2 DM is disorder characterized by insulin resistance and impaired insulin secretion.
Hyperglycaemia develops due to
(i) Peripheral resistance to action of insulin.
(ii) Increased hepatic glucose output.
(iii) Impaired pan- creatic β cell secretion of insulin.
Feature Type 1 DM Type2 DM
Investigations
152
Management
Symptoms Signs
• Polyuria, thirst • Dehydration
• Weight loss • Hypotension (postural or supine), tachycardia
• Weakness • Cold extremities/peripheral cyanosis
• Nausea, vomiting • Air hunger (Kussmaul breathing)
• Blurred vision • Smell of acetone
• Abdominal pain, leg cramps • Hypothermia
• Confusion, drowsiness, coma (10%)
153
Management
Ulnar deviation of the fingers with wasting of the ‘Swan neck’ deformity of the fingers.
small muscles of the hands and synovial swelling
at the wrists, the extensor tendon sheaths, the
metacarpophalangeal and proximal interphalangeal
joints.
155
Risk factors include low body weight, post menopausal women, family history of
osteoporosis, cigarette smoking and alcohol.
Degree of bone loss generally correlates with disease activity.
Laboratory investigations
Positive anti- CCP antibodies ( diagnostic)
High IgM rheumatoid Factor
High C- reactive protein & ESR
X-ray : Soft tissue swelling , joint space narrowing & bony erosions
ds
roi
ste
ar
Abatacept
cul
NS
Rituximab
AID
rti
Tocilizumab
a-a
a
nd
Anti-TNF #2
r
int
An
al
nd
Anti-TNF #1
ges
ra
ics
ula
usc
Combination DMARD
ram
Methotrexate + corticosteroids
Int
Diagnosis of RA
(DMARD = disease-modifying antirheumatic drug;
NSAID = non-steroidal anti-inflammatory drug;
TNF = tumour necrosis factor)
Clinical formula
Insidious Spine
onset, Positive anti-
subluxation, Methotrexate + corticosteroids
Rheumatoid multiple joint CCP
Osteoporosis, DMARD
Arthritis pain, antibodies,
osteopenia Anti TNF
stiffness and High CRP &
and bone Abatacept, Rituximab, Tocilizumab
swelling ESR
fractures.
158
Septic Arthritis
Most rapid and destructive joint disease
Due to haematogenous spread from either skin or upper respiratory tract;
infection from direct puncture wounds or secondary to joint aspiration
Risk factors include increasing age, preexisting joint disease , diabetes mellitus,
immunosuppression and intravenous drug misuse.
Clinical Features
Acute or subacute monoarthritis
Fever
Joint is usually swollen, hot and red, with pain at rest and on movement.
Lower limb joints, such as the knee and hip, are commonly targeted.
Patients with preexisting arthritis may present with multiple joint involvement.
Laboratory investigations
Blood cultures - maybe negative
Joint aspiration
The synovial fluid is usually turbid or bloodstained but may appear normal.
Synovial fluid analysis shows inflammatory effusion with neutrophil predominance
Diagnosis is confirmed by Gram stain of synovial fluid , blood cultures, and
genital/ pharyngeal nucleus acid amplification test for Neisseria gonorrhoea
Leucocytosis with raised ESR and CRP
Serial measurements of CRP and ESR are useful in following the
response to treatment.
159
Joint fluid characteristics
Non inflammatory Inflammatory
Normal (eg: crystals, RA)
Septic joint
(eg: OA)
Appearance Clear Clear Translucent or opaque Opaque
WBCs (mm )
3
<200 200 - 2,000 2,000 - 100,000 50,000 - 150,000
Gout
Inflammatory disease caused by deposition of monosodium urate monohydrate
crystals in and around synovial joints.
Hyperuricemia is the biologic hallmark of gout.
Causes of hyperuricaemia and gout
-86hPa
Clinical features
Acute monoarthritis:
Rapid onset, reaching maximum severity in 2–6 hours, and
often waking the patient in the early morning
During the attack, the joint shows signs of marked synovitis, swelling
and erythema with accom panying fever, malaise and even confusion,
especially if a large joint such as the knee is involved.
The first metatarso- phalangeal joint (podagra) is often involved.
Extraarticular tophi
Crystals may be deposited in the joints and soft tissues to produce irregular
firm nodules on extensor surfaces of fingers, hands, forearm, elbows, Achilles
tendons and sometimes the helix of the ear.
Renal impairment due to the development of interstitial nephritis as the
result of urate deposition in the kidney.
161
Podagra. Acute gout causing swelling, erythema Tophus with white monosodium urate
and extreme pain and tenderness of the first monohydrate crystals visible beneath the skin.
metatarsophalangeal joint.
Laboratory investigations
Synovial fluid analysis : demonstration of both intra- cellular and extracellular
needle-shaped negatively birefringent MSU crystals by polarizing microscopy.
Gram stain and culture to rule out infection.
Serum uric acid: normal levels do not rule out gout.
Urine uric acid: excretion of >800 mg/d on regular diet in the absence of drugs
suggests overproduction.
Tophaceous gout may be accompanied by a modest but chronic elevation in
ESR and CRP.
Joint x-rays: may demonstrate cystic changes, erosions with sclerotic margins in
advanced chronic arthritis.
Management
ACUTE GOUTY ARTHRITIS
NSAIDs: Treatment of choice when not contraindicated.
Oral colchicine, which works by inhibiting microtubule assembly in
neutrophils, is usually given in doses of 0.5 mg twice or 3 times daily.
Joint aspiration and Intraarticular glucocorticoids ( rule out septic arthritis )
Oral or intra muscular corticosteroids can also be highly effective in
treating acute attacks.
162
URIC ACID–LOWERING AGENTS
Indications
Recurrent frequent acute gouty arthritis, polyarticular gouty arthritis,
tophaceous gout, renal stones, prophylaxis during cytotoxic therapy.
Clinical formula
Synovial fluid NSAIDs,
Diuretics, analysis - Oral colchicine,
Low dose Aspirin, Negatively 1. Xanthine
Acute monoarthritis
alcohol, (Rapid onset)
birefringent MSU oxidase inhibitors
Recent Synovitis, Swelling crystals, (allopurinol,
Gout hospitalisation, Erythema Serum & Urine Uric febuxostat)
Low VIT C and Podagra, Tophus acid elevated 2. Uricosuric drugs
coffee intake, ^
CRP,ESR in (probenecid,
Lesch–Nyhan tophus, sulfinpyrazone)
syndrome Erosions in X-ray 3. Pegloticase
163
Clinical Features
• Constitutional: fatigue, fever, malaise, weight loss
• Cutaneous: rashes (especially malar “butterfly” rash), photosensitivity,
vasculitis, alopecia, oral ulcers
• Arthritis: inflammatory, symmetric, nonerosive
• Hematologic: anemia (may be hemolytic), neutropenia, thrombocytopenia,
lymphadenopathy, splenomegaly, venous or arterial thrombosis
• Cardiopulmonary: pleuritis, pericarditis, myocarditis, endocarditis. Pts are
also at increased risk of myocardial infarction usually due to accelerated
atherosclerosis.
• Nephritis: classification is primarily histologic
• GI: peritonitis, vasculitis
• Neurologic: organic brain syndromes, seizures, psychosis, cerebritis
Laboratory investigations
Antibodies
ANA ( Sensitive)
Anti-dsDNA & anti- smith (specific)
A raised ESR, leucopenia and lymphopenia are typical of active SLE, along
with anaemia, haemo lytic anaemia and thrombocytopenia, proteinuria and
elevated creatinine
Renal biopsy if evidence of glomerulonephritis
165
Management
Patients should be advised to avoid sun and UV light exposure and to
employ sun blocks (factor 25–50).
Mild to moderate disease
NSAID and hydroxychloroquine (200–400 mg daily)
Frequently, corticosteroids (prednisolone 5–20 mg/day), often in
combination with immunosuppressants such as methotrexate, azathio prine
or mycophenolate mofetil (MMF) are also necessary
Belimumab , B-lymphocyte stimulator (BLyS)-specific inhibitor ( limited to pts with
mild to moderate active disease.)
Life-threatening disease
Methyl prednisolone (10 mg/kg IV), coupled with cyclo phosphamide (15
mg/kg IV), repeated at 2–3weekly intervals for six cycles.
Mycophenolate mofetil has been used successfully in combination with
highdose steroids for renal involve ment in SLE
Related clinical question
Q. A 28 yr old woman comes to the casualty due to worsening headaches. She was first
evaluated for headache 4 weeks ago. At that time, examination was unremarkable and her
blood pressure was 132/86 mmHg. The patient was advised to take ibuprofen. However, she
continues to have worsening headache and reports fatigue. The patient has no fever ,
nausea, vomiting , abdominal pain, chest pain or dyspnea. She was treated for sunburn on
the face and arms 6 months ago and for sinus infection 4 weeks ago. Temperature is 37.2
C (99 F) , blood pressure is 170/110 mmHg, pulse is 82/ min and RR is 14/min. Examination
shows bilateral pitting ankle edema. Laboratory results are as follows
Complete blood count Serum chemistry
Hb 11 g/dL Blood urea nitrogen 40mg/dL
Platelets 75,000/mm Creatinine 2.5 mg/dL
Leukocytes 7,500/mm
Urinalysis
Protein 3+ C3( complement) 30 mg/dL
Bacteria none ( 88-206 mg/dL
Red blood cells 20-30/hpf
Casts Erythrocytes casts
What is the most likely diagnosis?
166
Clinical formula
Vasculitis
Takayasu’s disease
Granulomatous large-vessel vasculitis affecting the aorta and its major
branches, and occasionally the pulmonary arteries.
The typical age at onset is between 25 and 30 yrs, female preponderance.
The usual presentation is with claudication, fever, arthralgia and weight loss.
Examination may reveal loss of pulses, bruits and aortic incompetence.
Diagnosis is based on angiographic findings of coarctation, occlusion and
aneurysmal dilatation.
Treatment is with high-dose steroids and immunosuppressants, as for SLE.
167
Kawasaki disease
Vasculitis that mostly affects the coronary vessels.
Usually affecting children under 5 years
Clinical Features
Fever > 5 days + > 4 of the following
r r
Laboratory investigations
C- reactive protein and ESR are the inflammatory markers
that are elevated in KD which has to be done when < 3
diagnostic criteria are met in a child with > 5 days fever
Echocardiogram to rule out cardiac sequelae initially
and follow up after 2-6 weeks of treatment.
Treatment
Aspirin (5 mg/kg daily for 14 days) and intravenous
gammaglobulin (400 mg/kg daily for 4 days).
Aspirin reduces systemic inflammation and IVIg
significantly decreases risk of cardiac sequelae
Complication
Coronary artery aneurysm
Myocardial infarction & Ischemia
168
Strawberry tongue
Peeling of skin
Clinical formula
Fever, generalised
rash, including Coronary
Aspirin with artery
palms and soles, CRP , ESR
Kawasaki and conjunctival Echocardiogram
intravenous aneurysm
disease injection, inflamed
immunoglobulin Myocardial
oral mucosa, infarction &
cervical Ischemia
lymphadenopathy
169
Osteogenesis imperfecta
Autosomal dominant connective tissue disorder
mild OI severe OI
Reduced collagen production Formation of abnormal collagen
chains that are rapidly degraded
Clinical Features
Frequent fractures due to defective collagen in osteoid, osteoporosis.
Blue sclera due to thinning of sclera.
Dentinogenesis imperfecta- blue grey or yellow brown discolouration of
dentin though translucent weak enamel.
Joint hypermobility due to Ligamentous laxity
Conductive hearing loss and short stature.
The main radiographic features are osteopenia, bone fractures and bone deformities. They
result from constitutional bone fragility (cortical bone thinning, trabecular bone rarefaction)
but also from acquired bone fragility due to muscle wasting and immobilisation.
170
Management
Surgical reduction and fixation of fractures and correction of limb deformities,
Physiotherapy for rehabilitation of patients with bone deformity.
Bisphosphonates especially IV pamidronate in children (limited evidence)
Systemic sclerosis
Multisystem disorder characterized by thickening of the skin (scleroderma) and
distinctive involvement of multiple internal organs
Diffuse cutaneous SSc Limited cutaneous SSc
Rapid development of Long-standing Raynaud’s phenomenon
symmetric skin thickening Skin involvement limited to fingers
of proximal and distal (sclerodactyly), extremity distal to
extremity, face, and trunk. elbows, and face
At high risk for May have ‘CREST’ syndrome (Calcinosis,
development of visceral Raynaud’s, oEsophageal involvement,
disease early in course. Sclerodactyly and Telangiectasia).
171
Hands showing tight, shiny skin, sclerodactyly, Typical facial appearance in the CREST syndrome
flexion contractures of the fingers and thickening
of the left middle finger extensor tendon sheath.
Laboratory investigations
ESR is usually elevated and raised levels of IgG,
CRP values - increased in severe organ involvement or coexisting infection.
ANA is positive in about 70%,
30% of patients with DCSS have antibodies to topoisomerase 1 (Scl70).
60% of patients with CREST syndrome have anticentromere antibodies
Management
Raynaud’s should be treated by avoidance of cold exposure and calcium antagonists
Oesophageal reflux should be treated with proton pump inhibitors and antireflux agents.
Hypertension should be treated with ACE inhibitors
Joint involvement may be treated with analgesics and/or NSAID.
Pulmonary hypertension may be treated with bosentan.
Sjögren’s syndrome
Lymphocytic infiltration of salivary and lachrymal glands, leading to
glandular fibrosis and exocrine failure.
Clinical Features Risk factor
• Keratoconjunctivitis sicca • Non-erosive arthritis • Age of onset 40–60
• Xerostomia • Raynaud’s phenomenon • Female > male.
• Salivary gland enlargement • Fatigue • HLA-B8/DR3
Laboratory investigations
• Presence of autoantibodies (ANA, RF, anti-Ro/SS-A, anti- La/SS-B)
Elevated ESR and hypergammaglobulinaemia
Labial salivary gland biopsy, Schirmer’s test, Rose bengal staining.
Management
• Dry eyes: artificial tears, ophthalmic lubricating ointments
• Xerostomia: frequent sips of water, sugarless candy.
• Pilocarpine or cevimeline: may help sicca manifestations
• Hydroxychloroquine , Glucocorticoids for extraglandular manifestations
Fever of at least 3 weeks' duration with daily temperature elevation above 101°F and
remaining undiagnosed after 1 week of intensive study in the hospital.
• Classic PUO: Fever of at least 3 weeks' duration with temperature recorded as more than 101
°F (38.3°C) on several occasions, and the cause is not found despite three outpatient visits or 3
days of hospitalisation or 7 days of "intelligent" ambulatory investigations.
• Nosocornial PUO: A temperature of more than 38.3°C (101°F) developing on several
occasions in a hospitalised patient who is receiving acute care and in whom infection is not
manifest or incubating on admission.
• Neutropenic PUO: A temperature of more than 38.3°C (101°F) developing on several
occasions in a patient whose neutrophil count is below 500/mL or is expected to fall to that level
in 1 or 2 days.
• HIV-associated PUO: A temperature of more than 38.3°C (101°F) developing on several
occasions over a period of more than 4 weeks for outpatients or more than 3 days for hospitalised
patients with HIV infection.
Aetiology
176
Treatment
• Treatment of underlying causes detected after investigations.
• Empirical broad-spectrum antibiotics.
• Empirical antitubercular treatment.
• Rheumatic fever and Still's disease respond dramatically to aspirin and NSAIDs.
• Temporal arteritis and polymyalgia rheumatic respond to glucocorticoids dramatically.
Dengue Fever
a.k.a Break Bone Fever
Caused by Dengue viruses 1-4 ( Flavirisues )
Principal Reservoir - Non human primates
Vectors - Mosquitos ( Aedes aegypti , A.albopictus )
Syndromes associated
i. Dengue Shock Syndrome
ii. Dengue hemorrhagic fever
IP - 4 - 7 days
Symptoms Signs
Sudden Onset fever ( High grade - 40 C) Transient Macular Rash on 1st day
Frontal Headache Adenopathy
Retroorbital pain Palatal vesicles
Back pain with severe myalgias Scleral injection
Lab Diagnosis
Leukopenia
Thrombocytopenia
Elevated Serum Amino Transferases
4 fold rise in Anti - Dengue Ig G antibody
IgM ELISA
Antigen detection by ELISA or RTPCR
Severe Dengue
Dengue Hemorrhagic Fever and Dengue Shock Syndrome are most severe
manifestations.
Usually occurs several weeks after convalescence when transient protection against
reinfection with heterotypic dengue virus wanes.
Identified by bleeding tendencies or overt bleeding in the absence of underlying causes.
Shock is results from increased vascular permeability.
Clinical formula
MEASLES (RUBEOLA)
• Measles is caused by a paramyxovirus (RNA virus) infection.
• Mode of spread is by droplet infection.
• Incubation period is of about 10 days.
• Period of infectivity is from 4 days before and 2 days after the onset of rash. People with
compromised immunity can continue to shed virus for the entire duration of illness.
Clinical Features
• An erythematous, nonpruritic, maculopapular rash begins at the hairline and behind
the ears, spreads down the trunk and limbs to include the palms and soles, can become
confluent, and begins to fade (in the same order of progression) by day 4.
• Koplik’s spots are pathognomonic for measles and consist of bluish-white dots ~1
mm in diameter surrounded by erythema. They appear on the buccal mucosa ~2 days
before the rash appears and fade with the onset of rash.
179
Diagnosis
• Serologic testing is the most common method of laboratory diagnosis. Measles-
specific IgM is usually detectable within 1–3 days of rash onset.
• Viral culture and reverse-transcription PCR analysis of clinical specimens are
used occasionally to detect measles.
TREATMENT
• Supportive care is the mainstay of treatment, as there is no specific antiviral
therapy for measles. Prompt antibiotic therapy for pts with secondary bacterial
infections helps reduce morbidity and mortality risks.
• Vitamin A (for children ≥12 months: 200,000 IU/d for 2 days) is recommended by
the World Health Organization (WHO) for all children with measles.
Clinical formula
• Serologic testing:
Erythematous, Measles- specific IgM Vitamin A (for
nonpruritic, within 1–3 days of rash children ≥12
MEASLES maculopapular rash onset. months: 200,000
Koplik’s spots • Viral culture and IU/d for 2 days)
reverse-transcription PCR
ZIKA FEVER
i. Causative agent : Zika virus (Flaviviridae)
ii. Spread by Aedes aegypti and A.albopictus
iii. Mode of transmission :
- Zika can be transmitted from men and women to their sexual partners.
- Can spread by vertical (mother to child) transmission.
- Can be transmitted through blood transfusion.
180
Symptoms iv. Lab diagnosis : RT-PCR
Acute onset of Fever v. Prevention and control : relies on reducing mosquitoes
Red eyes (conjunctivitis) through source reduction (removal and modification of
Joint pains breeding sites) and reducing contact between mosquitoes
Headache & malaise and people.
Maculopapular rash
Maculopapular rash
Transplacnetal transmission to
baby can cause :
i. Severe microcephaly
ii. Decreased brain tissue with a specific pattern of brain damage - Microencephaly
iii. Damage to the back of the eye - Macular scarring
iv. Joints with limited range of motion, such as club foot - CTEV
v. Too much tone restricting body movements after birth - Hypertonia
Clinical formula
Reducing mosquitoes
Acute onset of Fever Severe microcephaly
through source reduction
Red eyes Microencephaly (removal and modification of
ZIKA (conjunctivitis) Macular scarring Lab diagnosis : breeding sites) and
FEVER Joint pains CTEV RT-PCR reducing contact between
Headache & malaise Hypertonia
mosquitoes
Maculopapular rash
and people.
Investigations
● Slit skin smears: dermal material is scraped on to a glass slide and acid-
fast bacilli may be seen on microscopy.
● Skin biopsy: histological examination may aid diagnosis.
● Neither serology nor PCR testing for M. leprae DNA is sensitive or specific
enough for diagnosis.
Management
Clinical formula
Macules or plaques. Tuberculoid Dapsone 2 mg/kg daily, not
exceeding 100 mg
patients have a few hypopigmented
Slit skin Clofazimine 50 mg daily or 100 mg
lesions. In lepromatous leprosy,
three times a week
leprosy papules, nodules or diffuse smears, Skin
Rifampicin, 450 mg (for those who
infiltration of the skin occur. biopsy are <35 kg) or 600 mg (for those who
Confluent lesions on the face can are <35 kg), on 2 consecutive
lead to a ‘leonine facies’ days a month.
Hydatid disease
Parasitic infection caused by Echinococcus granulosus (EG)
Characterized by cystic lesions
The liver is the most common site of echinococcal cyst, followed by the lungs
Clinical Features
Hepatic lesions often present as palpable masses or abdominal pain.
Obstruction of bile duct may result in obstructive jaundice.
Intrabiliary extrusion of calcified hepatic cysts can present with recurrent
cholecystitis.
Rupture of a hydatid into the bile duct, peritoneal cavity, lung, pleura or bronchus
may produce fever, pruritus, urticarial rash or an anaphylactoid reaction that may
be fatal.
A pulmonary hydatid may rupture producing cough, chest pain or haemoptysis.
Central nervous system involvement may produce epilepsy or blindness.
IMAGING FINDINGS
CHEST X-RAY- RUPTURE CYST
HOMOGENOUS ROUND OR OVAL EVACULATION OF CONTENTS IN
MASSES WITH SMOOTH BORDERS PARTIAL RUPTURE
SURROUNDED BY NORMAL LUNG AIR/FLUID LEVEL CAN BE SEEN
TISSUE
184
Treatment
• Surgical excision of the cysts is the treatment of choice.
• In inoperable cases, "high-dose" albendazole (7.5 mg/kg twice daily)
should be given for 1-3 months.
• In selected cases, percutaneous aspiration, infusion of scolicidal agents
(e.g. 95% ethanol or hypertonic saline) and reaspiration (PAIR) can be
done. It is followed by albendazole treatment for 1 month.
Clinical formula
Palpable masses or
abdominal pain, obstructive Radiological signs Surgical excision
Hydatid jaundice. Rupture cyst: Air fluid level of the cysts
disease fever, pruritus, urticarial serpent sign high-dose
rash, cough, chest pain or Water lily sign albendazole
haemoptysis, epilepsy or
blindness.
185
Hepatitis B infection
Interpretation
186
COVID-19
Causative agent : SARS-CoV-2 virus
Transmission :
- Asymptomatic carriers
- Respiratory droplets
(Coughing, sneezing)
- Contact
- Aerosols in closed spaces
Clinical features :
- Fever
- Cough
- Sore throat
- Anosmia
- Shortness of breath
- Rhinorrhea - infrequent
Complications :
(a) ARDS
(b) Acute respiratory failure
(c) Acute liver/ kidney injury
(d) DIC
(e) Secondary infection
(f) Neurological complications
Laboratory diagnosis :
a. NAATs
b. rRT-PCR : gold standard
c. True Naat : Not that sensitive (50 ~ 80 %)
d. Serological tests :
(i) Ig M and Ig G antibodies (blood samples) (iv) Elevated CRP
(ii) ELISA, immunochromatography (v) Elevated LDH, AST
(iii) Accurately assess prior infection and (vi) Lymphopenia
immunity to SARS-CoV-2 (vii) Elevated ESR
(viii) Increased bilirubin
(ix) Elevated D-dimer
187
Management
COVID-19 Positve case
Clinical formula
- Fever Isolate yourself
rRT-PCR : gold standard Use a mask,
- Cough Elevated CRP, Elevated
- Sore throat Take rest and drink a lot of
LDH, AST, Lymphopenia, fluids to maintain adequate
COVID 19 - Anosmia Elevated ESR, Increased
- Shortness of breath hydration.
bilirubin, Elevated D- Frequent hand washing
- Rhinorrhea dimer Alcohol-based sanitizer.
Clinical stage 3
Fungal nail infections
Unexplained severe weight loss (>10% of presumed or measured body weight)
Unexplained chronic diarrhoea for longer than one month
Unexplained persistent fever (above 37.6°C intermittent or constant for >1
month)
Persistent oral candidiasis
Oral hairy leucoplakia
Pulmonary tuberculosis
Severe bacterial infections
Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis
Unexplained anaemia (<8 g/dL), neutropenia (<500/µL) or chronic
thrombocytopenia (<50,000/µL)
Clinical stage 4
HIV wasting syndrome
Pneumocystis pneumonia
Recurrent severe bacterial pneumonia
Chronic herpes simplex infection
Oesophageal candidiasis
Extrapulmonary tuberculosis
Oral Kaposi’s sarcoma.
Kaposi's sarcoma
Cytomegalovirus infection
Central nervous system toxoplasmosis
HIV encephalopathy
Extrapulmonary cryptococcosis including meningitis
Disseminated non-tuberculous mycobacterial infection
Progressive multifocal leucoencephalopathy
Chronic cryptosporidiosis (with diarrhoea)
Chronic isosporiasis
Disseminated mycosis (coccidiomycosis or histoplasmosis)
Recurrent non-typhoidal Salmonella bacteraemia
Lymphoma (cerebral or B-cell non-Hodgkin) or other solid HIV-associated
tumours Invasive cervical carcinoma
Atypical disseminated leishmaniasis
190
Laboratory diagnosis :
Treatment
Clinical formula
Neurology
CSF analysis
CSF is formed from mainly the choroid plexuses of lateral, third and fourth ventricles.
Some may originate as tissue fluid formed in the brain substance.
It leaves the ventricular system through the apertures in the roof of the fourth
ventricle and flows through the cerebral and spinal subarachnoid spaces.
It is returned into venous sinuses by the arachnoid villi
Analysis of CSF is of diagnostic value. Disorders of central nervous system
and some peripheral nervous system may be made out by CSF examination.
Functions
Serves as a cushion between the CNS and surrounding bones, thus protecting CNS
against mechanical trauma.
Serves as a reservoir and assists in the regulation of intracranial volume as a buffer
Nourishment of the nervous tissue.
Removal of products of neuronal metabolism.
lumbar puncture
Contraindications
Raised ICP
Spinal deformity
Local infections
Coagulation disorders
Proper positioning of a pt
in the lateral decubitus
position. Note that the
shoulders and hips are in a
vertical plane; the torso is
perpendicular to the bed.
194
Subacute combined degeneration of spinal cord
TREATMENT
Vit B12 supplementation
195
Clinical formula
Neurocysticercosis
Most common parasitic disease of the nervous system
By the ingestion of food contaminated with the eggs of the parasite T. solium.
Leading cause of adult onset epilepsy
Clinical Features
• Presence of adult worm in the intestine is generally asymptomatic.
• Superficially placed cysts may be palpable under the skin or mucosa as pea-like ovoid
bodies.
• The dead larvae may invoke marked tissue response with muscular pain, weakness,
fever and eosinophilia.
• Neurocysticercosis results from brain cysts. It may manifest as meningoencephalitis,
epilepsy, personality changes, staggering gait, space-occupying lesion, stroke (due to
inflammatory changes in the wall of intracranial arteries located in the vicinity of
cysticerci) or hydrocephalus.
MRI T2 image showing neurocysticercosis Diagnosis Multiple neurocysticercosis showing 'starry sky appearance'
196
Severe
Colloidal Larval
inflammatory Ring enhancing, Degenerating degeneration
stage reaction perilesional edema scolex
Eosinophilia
Focal nodular
Granular Astro enhancing necrotic Degenerating structure,
gliosis scolex bladder
stage lesion also with scolex in
edema disintegration
Calcified
calcified nodule Small hyper dense nodules without
stage Intense gliosis perilesional edema
Diagnosis
• Eggs and proglottids in stool.
• Soft tissue radiographs may show calcified cysts (cigar-shaped) in muscles.
• CT scan of the brain may show calcified spots, solid nodules, cystic lesions containing a
scolex or hydrocephalus.
• CT scan is more sensitive than MRI in identifying calcified lesions, while MRI is better
for identifying cystic lesions and enhancement.
• CSF shows mononuclear pleocytosis and presence of eosinophils.
• In CSF, specific enzyme-linked immunoelectrodiffusion transfer blot (EITB) using
lentil lectin purified glycoproteins is highly sensitive and specific.
• Histological examination of the excised subcutaneous nodule can establish a specific
diagnosis.
Treatment
IV DEXAMETHASONE- along with Mannitol followed by oral prednisolone
Antiparasitic agents- PRAZIQUNTEL, ALBENDAZOLE
Clinical formula
CT scan of the brain,mCSF
Meningoencephalitis, shows mononuclear pleocytosis
epilepsy, personality and presence of eosinophils, In IV DEXAMETHASONE
Neurocysti changes, staggering
cercosis CSF, specific enzyme-linked PRAZIQUNTEL,
gait, space-occupying immunoelectrodiffusion transfer ALBENDAZOLE
lesion, stroke or blot (EITB) using lentil lectin
hydrocephalus. purified glycoproteins
Bell's palsy.
Bell’s palsy is an acute, apparently isolated, lower motor neuron facial palsy for
which no cause can be found. Presumed to be viral due to HSV 1 (viral genomic
sequences detected).
Clinical features
• Paralysis of all the muscles of facial expression on the side of palsy.
• Drooping of corner of mouth, effacement of creases and skin fold on the affected side.
• Weakness of frowning and eye closure as the upper facial muscles are weak.
• Drooling of saliva from angle of mouth.
• On asking the patient to show his teeth, the angle of mouth deviates away from the
side of lesion.
• Upon attempted closure of the eyelid, the eye on the paralysed side rolls upwards
(Bell's phenomenon).
• Corneal ulceration due to inability to close the eye during sleep.
198
Investigations
• No specific confirmatory diagnostic procedure.
• Electrophysiological tests (EMG or electromyography) may help in prognostication.
• To rule out alternate diagnosis, appropriate diagnostic procedures maybe necessary.
Treatment
• If patient is seen early (within 3 days), a short course of prednisolone maybe given.
Usually, prednisolone is given at 1 mg/kg/day for the 1st week, with the dosage
tapering off over the 2nd week.
• Addition of acyclovir does not alter recovery.
• Adhesive tape to keep the eye closed so as to prevent corneal ulceration.
Aetiology
Herpes zoster of geniculate ganglion
Clinical Features
• Onset is with severe pain in external ear,
followed by appearance of vesicles in the
external auditory meatus, and occasionally on
tongue and pharynx, along with LMN facial
paralysis.
Eighth nerve palsy maybe associated leading
to nausea, vomiting, vertigo, nystagmus,
tinnitus and hearing loss.
• Complete recovery is less likely than in
Bell's palsy.
Treatment
• Analgesics.
• Oral acyclovir 800 mg five times a day is useful if started early (within 72 hours)
along with corticosteroids.
• Other agents are famciclovir (500 mg three times a day) and valaciclovir (1 g
three times a day).
• ldoxuridine (5% solution) maybe applied over the vesicles in early stages.
199
RELATED CLINICAL QUESTION
Q.A 48-year-old man comes to thecasualty due to facial drooping and he had difficulty
closing the left eye to the sunlight while driving to work. Four hours later, he was unable
to sip drinks through a straw.On physical examination, there is left facial asymmetry
with drooping of the left corner of the mouth and flattening of the nasolabial fold. He is
unable to fully close the left eye.What is the probable diagnosis?
Clinical formula
Paralysis of all the muscles of EMG or Prednisolone,
facial expression, Drooping of electromyography acyclovir.
Bell’s corner of mouth, Weakness of To rule out alternate Adhesive tape to
palsy frowning and eye closure, diagnosis, appropriate keep the eye closed
Drooling of saliva from angle of diagnostic procedures so as to prevent
mouth, angle of mouth maybe necessary. corneal ulceration.
deviates, Bell's phenomenon.
EPILEPSY
Brief recurrent disorder of cerebral function that is usually associated with
disturbance of consciousness and accompanied by a sudden, excessive electrical
discharge of cerebral neurones..
200
status epilepticus
• Status epilepticus denotes sustained epileptic activity, and is clinically diagnosed with
one of the following two:
• Two fits occur without recovery of consciousness in between.
• A single fit lasts longer than 30 minutes with or without loss of consciousness.
• Condition is fatal or results in severe morbidity if not treated rapidly.
Causes
• Sudden antiepileptic withdrawal
• Metabolic disorders-hypoglycaemia and hyponatraemia
• Alcohol or benzodiazepine withdrawal
• Infections-encephalitis and meningitis
• Occasionally, brain tumour or trauma
• Priority should be to control seizures as fast as possible, along with
identification of an underlying cause and its correction.
• Simultaneously, BP, acidosis, ventilation and electrolyte balance are taken care of.
Underlying cause should be rectified appropriately.
Investigations
Cerebral imaging: After a single seizure, head CT or MRI is advisable
EEG: performed very soon after a seizure than after an interval. help establish the
type of epilepsy and guide therapy;
Other investigations: These should identify any metabolic, infective, inflammatory or
toxic causes. They include FBC, ESR, CRP, U&Es, glucose, LFTs, CXR, syphilis serology,
HIV, tests for collagen disease and CSF examination.
Clinical formula
Altered consciousness , epileptic cry. Fit starts 1st line
Head CT or MRI, Focal onset GTCS
simultaneously with gener alised tonic state,
EEG, FBC, ESR, Lamotrigine
unconscious and cyanosed, does not breathe, pupils GTCS
are dilated followed by clonic state where rhythmic CRP, U&Es,
EPILEPSY jerks appear,, Tongue maybe bitten and urinary or glucose, LFTs,
Sodium valproate
Levetiracetam
bowel incontinence may occur followed by postictal CXR, CSF Absence Myoclonic
phase where patient passes off into sleepy state and examination. Ethosuximide Sodium
may have headache and vomiting. valproate
STROKE
An ischemic deficit that resolves rapidly without radiologic evidence of an infarction is
termed a transient ischemic attack
risk factors
203
Clinical features
Unilateral weakness is the classical presentation of stroke. The weakness starts
suddenly, and progresses rapidly in a hemiplegic pattern.
Dysphasia and dysarthria are the usual speech manifestations in stroke.
Monocular blindness in stroke can be caused by reduced blood flow in the internal carotid
or ophthalmic arteries.
Stroke causing damage to the cerebellum and its connections can present as acute
ataxia.
Sudden severe headache is the cardinal symptom of subarachnoid haemorrhage but also
occurs in intracerebral haemorrhage.
Seizure is unusual in acute stroke but may occur in cerebral venous disease.
Coma is an uncommon feature of stroke, though it may occur with a brainstem event.
Wallenberg's syndrome
(lateral medullary syndrome)
Due to an infarct that is located at dorsolateral medulla and occurs due to occlusion
of posterior inferior cerebellar artery, its branch or parent vertebral artery itself.
Symptoms consist of sudden onset vertigo, vomiting, dysphagia and ataxia.
Clinical formula
Full blood count, ESR, Blood
Unilateral weakness glucose, urea, proteins, Chest X- Antiplatelet agents-
Dysphasia and dysarthria ray, ECG Combination of aspirin and
STROKE Monocular blindness, CT scan or diffusion weighted MRI clopidogrel
acute ataxia. of head,Carotid Doppler Correction of risk factors,
Sudden severe headache Arteriography, CT or MR Anticoagulants, Surgery-
Seizure , Coma angiography, Antinuclear factors, carotid endarterectomy.
Cholesterol, Coagulation studies
206
Subarachnoid haemorrhage
Investigations
CT Scan- shows blood in the subarachnoid space (if done in the first few days) and
presence of intracerebral haematoma, hydrocephalus, associated brain ischaemia and
occasionally location of aneurysm itself.
Lumbar Puncture- CSF will be uniformly blood stained in the initial hours and becomes
xanthochromic in later days (first appears after 4-6 hours of the bleed).
Angiography- It is needed to locate the site of aneurysm
CT Angiography- A rapid, readily available, less invasive alternative to catheter
angiography and is equivalent to conventional angiography for demonstrating larger
aneurysms.
Management
Immediate administration of antifibrinolytic agent tranexamic acid (1 g IV, followed
by 1 g every 6 hours) maybe useful to reduce the rate of early aneurysm re-
bleeding.
Pain management, sedation and control of hypertension are also important in the
prevention of aneurysm re-bleeding.
In conscious patients without evidence of raised ICP, active hypertension treatment
is indicated.
Calcium blocking agent nimodipine (60 mg orally every 4 hours) provides a modest
but significant improvement in outcome by reducing cerebral arterial vasospasm.
Anticonvulsants are recommended for prophylaxis.
Absolute bed rest for 4 weeks is advised
207
Wernicke's encephalopathy.
Wemicke's encephalopathy is an acute neuropsychiatric condition due to an initially
reversible biochemical brain lesion caused by depletion of vitamin B1 (thiamine).
Causes
• Chronic alcohol use
• Protein-calorie malnutrition from malabsorption or forced/self-imposed inadequate diet
• Patients with protracted vomiting
• Carbohydrate loading (intravenous or oral) when thiamine stores are minimal
• Chronic renal failure
• Hyperalimentation, AIDS, and drug misuse
• Genetic abnormality of transketolase enzyme
Clinical Features
• Mental disturbances:
• Progressive depression of the state of consciousness.
• Global confusional apathetic state, profound listlessness,
inattentiveness and disorientation.
• Paralysis of eye movements:
• Vlth nerve palsy and diplopia.
• Nystagmus.
• Internuclear ophthalmoplegia.
• Ataxia of gait-this affects stance and gait predominantly.
Management
• Immediate administration of thiamine.
• Magnesium is often required as it is a cofactor required for normal functioning of
thiamine-dependent enzymes.
• Intravenous glucose solutions should not be given particularly in malnourished
patients, as they may exhaust the patient's reserve of B vitamins and either
precipitates Wernicke's disease in a previously unaffected patient or cause a rapid
worsening of an early form of the disease.
NEURODEGENERATIVE DISEASES
Alzheimer’s disease
Progressive neurodegenerative disease resulting in decline in cognitive functions
together with declining activities of daily living (ADL) and behavioural disturbances.
It is the most common cause of cognitive impairment in elderly persons.
Aetiology
Genes that increase the probability of sporadic Alzheimer's disease include the
allele E4 of apolipoprotein E (APOE) and the sortilin-related receptor l . (SORL
l ) gene (which is involved in cholesterol transport, 13-amyloid formation and
APP processing).
Early onset of Alzheimer's disease (onset < 60 years) is uncommon and is usually
autosomal dominant. Three gene mutations have been identified: APP gene located on
the chromosome 21; the presenilin-1 (PSI) and presenilin-2 (PS2) genes located on
chromosomes 14 and 1 respectively.
Clinical features
The key feature is impairment of the ability to remember new information.
Memory impairment is gradual and usually associated with disorders of other cortical
functions.
Both short-term memory and long-term memory are affected.
Later in the disease, patients commonly deny their disabilities, and additional
features are apraxia, visuo-spatial impairment, depression and aphasia.
management
Investigation is aimed at excluding the less common treatable causes of dementia
Anticholinesterases (donepezil, rivastigmine, galantamine) and the NMDA receptor
antagonist memantine have been shown to be of some benefit.
Depression should be treated with antidepressants. Support for carers is crucial.
Parkinson’s Disease
Parkinsonism is a clinical syndrome involving bradykinesia, plus at least one of
the following three features: tremor, rigidity and postural instability.
All patients with Parkinson's disease have parkinsonism, but not all patients with
parkinsonism have Parkinson's disease.
210
Causes
Clinical features
The presentation is usually asymmetrical, e.g. a resting tremor in an upper limb.
Typical features of an established case include:
Bradykinesia: Slowness in initiating or repeating movements, impaired fine
movements (causing small handwriting) and expressionless face. The patient is slow to
start walking, with reduced arm swing, rapid small steps and a tendency to run
(festination).
Tremor: Present at rest (4–6 Hz), diminished on action; it starts in the fingers/thumb
and may affect arms, legs, feet, jaw and tongue.
Rigidity: Cogwheel type mostly affects upper limbs; plastic (lead-pipe) type mostly
affects legs.
Non-motor symptoms may precede typical motor symptoms and include:
● Depression
● Anxiety TRAP:
● Cognitive impairment Tremor at rest,
Rigidity,
Akinesia (or bradykinesia)
Postural instability.
Investigations
Diagnosis is clinical.
CT may be needed if any features suggest pyramidal, cerebellar or autonomic
involvement, or if the diagnosis is in doubt, but is usually normal for age.
Patients <50 yrs should be tested for Wilson’s disease and Huntington’s disease.
211
Management
Clinical formula
---
• Set exam count down timer
• Make your own study timetable
• Revise with in-app spaced =$lfloto1\--- ......""""'-,1\--
repetition technology e 0 e 0
•.•, '"'t;I"""
�o"-.
--- ............ -
• Stylez Compatible
\�
i • Add your own notes
...... • Bookmark option
• and many more ...
""""""
MRP: 649